
Division of Trauma, Surgical Critical Care, Burns and Acute Care
Surgery Handbook
Department of Surgery University of California San
Diego
2nd edition
(2012)
M. EMERGENCY AND DISASTER PREPAREDNESS..................................................................................................... 96
C-spine-Evaluable.................................................................................................................................... 102
Penetrating
Neck Trauma....................................................................................................................... 105
Blunt Chest Trauma................................................................................................................................ 106
Penetrating Chest
Trauma-Stable........................................................................................................... 107
Penetrating Chest
Trauma-Unstable...................................................................................................... 108
Penetrating Chest Trauma-Agonal/In Extremis...................................................................................... 109
Blunt Abdominal Trauma........................................................................................................................ 110
Penetrating Abdominal Trauma-Stab Wound........................................................................................ 111
Penetrating Abdominal Trauma-GSW.................................................................................................... 112
Anticoagulation-No CHI.......................................................................................................................... 113
Anticoagulation-CHI................................................................................................................................ 114
Blunt Pelvic
Fracture............................................................................................................................... 115
Intracranial Hypertension....................................................................................................................... 116
STEER....................................................................................................................................................... 117
The UCSD Division of Trauma, Surgical Critical Care & Burns is part of the Department of Surgery. The Division was designed to respond to any emergency call 24/7 with fully equipped state-of-the art trauma bays. Whether a trauma or a burn victim, they will be seen by a multidisciplinary team of specialists including trauma surgeons, trauma nurses, neurosurgeons, orthopedic surgeons, plastic surgeons and spine specialists. All aspects of care and all subspecialties in medicine are coordinated in the care of each trauma/burn patient under the direction and leadership of Raul Coimbra, MD, PhD, FACS, the Monroe E. Trout Endowed Chair of Surgery; our team is always on standby and ready to provide care to critically injured patients. Our mission is to save patients’ lives and send them back to their families and loved ones.
The care of the most severely ill or injured patients requires the cooperation of multiple specialties, but we at UCSD believe that surgeons with advanced knowledge and training are the vital central element. Our educational philosophy is to teach not only the individual basics of care of sick surgical patients, but to teach the integration of care through multiple practitioners in the interdisciplinary process. By providing truly comprehensive care for trauma patients – from intensive care through intermediate care, acute care, and rehabilitation – the UCSD Trauma Center remains committed to decreasing the mortality rate from traumatic injuries in the San Diego Region.
I would like to acknowledge all members of the Division for their hard work, dedication, and commitment to our mission. I would also like to thank Dr. Dennis Kim for overseeing the preparation and publication of this manuscript.
Raul Coimbra, MD, PhD, FACS.
The Monroe E. Trout Professor of Surgery Executive Vice-Chairman, Department of Surgery
Chief, Division of Trauma, Surgical Critical Care, and Burns University of California San Diego School of Medicine
|
Day |
Time |
Conference |
Location |
|
Monday |
0900-1000 |
Multidisciplinary Discharge
Planning/Rehabilitation Rounds |
SICU |
|
Tuesday |
0715-0815 |
Administrative
Division Meeting |
Trauma Offices Conference
Room 5 |
|
Tuesday |
1500-1700 |
Trauma
Conference |
3rd Floor Conference Room Inpatient Hospital Tower |
|
Wednesday |
1300-1700 |
White Surgery
Clinic |
3rd Floor Outpatient Suite 1 |
|
Thursday |
1500-1600 |
Basic
Science Research Meeting |
CTF C 301 |
|
Friday (every 2nd & 4th) |
0700-0800 |
Orthopedics/Trauma
Conference |
ACR |
|
Friday (monthly TBA) |
0700-0800 |
Neurosurgery/Trauma
Conference |
CTF C-301 |
|
Friday |
0830-1100 |
Trauma
Clinic |
3rd Floor Outpatient Suite 1 |
|
Friday |
0900-1000 |
International Trauma
Teleconference |
Trauma Offices Conference
Room 5 |
|
Friday |
1300-1400 |
Basic
Science Lab Meeting |
CTF C 301 |
|
Faculty |
Office |
Pager |
e-mail |
|
Dr. Raul Coimbra |
37100 |
4992 |
|
|
Dr. Bruce Potenza |
36002 |
4990 |
|
|
Dr. Jay Doucet |
10791 |
1490 |
|
|
Dr. Vishal Bansal |
37024 |
2705 |
|
|
Dr. Jeanne Lee |
37129 |
2623 |
|
|
Dr. Leslie Kobayashi |
37120 |
0185 |
|
|
Fellows |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NPs/PAs |
|
|
|
|
Jan Dove |
10449 |
4717 |
|
|
Gabrielle Riviello |
33434 |
4989 |
|
|
Carla Salinas |
35284 |
8191 |
|
|
Trauma
Program |
|
|
|
|
Sharon Pacyna, Manager |
37191 |
5007 |
|
|
Pat Stout, Assistant Manager |
37523 |
5057 |
|
|
Jan Ferree, Prevention Coordinator |
13342 |
|
|
|
Dale Fortlage, Programmer/Analyst |
36666 |
|
|
|
Burn Program |
|
|
|
|
John Noordenbos, Coordinator |
32352 |
|
|
Location |
Extension |
Location |
Extension |
|
Anesthesia Code Pager |
2622 |
Operator |
36222 |
|
Angiography |
35214 |
Resus Room-Trauma Bay |
32747 |
|
Blood Bank |
35640 |
Resus Room-Radiology |
35306 |
|
Case Manager Pager |
5069 |
Security |
33762 |
|
CT Scan Room |
36893 |
SICU |
37428 |
|
Main OR |
36040 |
Trauma Clinic |
36886 |
|
MICN Radio Room |
37644 |
Trauma Office |
37200 |
No patient is to be
transferred to another service or facility during the first 24 hours of
admission. The
only exception may be a trauma patient with single system orthopedic injury.
Each case will be reviewed by the PI process.
a.
No medical student is to complete the formal H & P form. Only residents should fill out the
hospital H&P. The Attending Physician must cosign the H&P. The code
status must be checked off. The pain score must be noted. The day-to-day
"oversight" responsibility for this belongs to the Chief Resident on
the Trauma Service.
b. Everyone who touches or assesses
the patient in a meaningful way in the resuscitation room or the ED should
write a progress note.
c.
Medical student notes in the chart must be cosigned by a licensed
physician. An intern is not yet a licensed physician.
d.
Date and time ALL notes that are placed in the chart. This is especially
important for the tertiary exam and for serial physical exams of the abdomen,
chest, C-spine, etc.
Resuscitation Room Orders Sheet
(see Appendix A Resuscitation Room
Orders Sheet)
Preoperative
Notes
Documentation of a discussion with the patient or their family regarding risks/benefits/alternative choices of the proposed operation should be documented in the patient’s chart.
Blood Product
Transfusion Consents
Patients who are able to sign must sign a blood transfusion consent form.
Emergent
Operative Informed Consent
If a patient is unable to provide informed consent for her/himself, the operating surgeon MUST write a progress note stating specifically the indications for the surgery (i.e. life-threatening/emergent), the patient’s inability to consent, and inability to contact family.
OR
Resuscitations
OR resuscitations are considered operations. Therefore, an operative dictation is required.
Bedside
Procedures
The procedure note is expected to be placed in the chart immediately following any bedside procedure. When available, this should be filled out in the EPIC electronic system.
Surgical Time-out
Medical Center Policy (MCP) 561.2 requires that a time-out be conducted every time an invasive procedure is to be performed. At a minimum, the surgical timeout will include verification of the correct:
i.
patient identity
ii.
side and site
iii.
procedure to be performed
If a discrepancy is discovered, the discrepancy shall be resolved before the surgery/procedure is started.
Operatives
Cases
A Brief Operative Note (see Appendix B Brief Operative Note) is to be placed in the chart immediately following any operative procedure. It is absolutely essential that this be done by the time the patient is in the recovery room or ICU. Until the dictated operative note is transcribed, it is the only record of the operative procedure. Please include diagrams when applicable. This should be filled out in the EPIC electronic system.
Dictated operative notes should be completed as soon as the operation is over. The dictated note must be done within 24 hours by the Fellow or Attending Surgeon.
Transfer/Off-Service
Notes
A transfer or off-service note should be included in the following situations:
i.
transfer of a patient from the SICU to a lower level or care
ii. during the change of rotations
This note should be brief and include a list of injuries, studies and interventions performed, as well as followup/studies to be completed.
Discharge
Summary
The discharge summary is completed at the time of discharge and lists the:
i.
admission and discharge diagnoses
ii. operations
iii. condition at discharge
iv. activity
v. medications
vi. laboratory tests to be done
before follow-up.
This note facilitates rehabilitation and clinical follow-up and should provide concise information to consultants and housestaff who will be rotating on the trauma service in the future. This should be completed on the EPIC electronic system where a trauma discharge outline is available and should be used.
e.
The Trauma MD will also be required to assist with completion of
essential financial forms and may be contacted directly by the Patient Services
Representative (PSR).
a. When there is an admission
to trauma, the resuscitation monitoring nurse will call the page operator (x364440) and request a Trauma Group Page.
The resuscitation nurse will indicate the ETA and mode of arrival (ground, air,
or from the ED) to the page operator.
b. The Trauma Group Page includes:
i.
Trauma Service Physicians
ii.
SICU and OR Charge Nurses
iii.
Trauma Program Managers
iv.
Nursing Supervisor
v.
Radiology resident
vi.
ED Attending/ED resident
vii.
Respiratory Therapy
viii.
X-ray Technologist
ix.
Case Managers
x.
OB/Trauma registration
xi.
Telecommunications
xii.
Social Worker
c. If PTA information about a
patient suggests the need for intubation
or for the neurosurgery physician to be present on admission, the resuscitation
nurse should confer with the Trauma Service and ask the page operator to page
anesthesia or the neurosurgeon on call to the resuscitation room.
d. If the paramedic, MICN,
resuscitation nurse or trauma physician determines that the patient will be an
OR resuscitation, the resuscitation nurse will direct the page operator to
input “OR resus” on the group page.
e. As a courtesy, the
resuscitation nurse receiving the call should notify the OR of an expected
admission and provide a brief report.
f. Trauma patients initially
triaged to the ED may subsequently be “upgraded” and transferred to
the resuscitation room as a Trauma Team Activation. The request must be from
the ED Attending to the Trauma Fellow/Attending.
g. Trauma Consult Protocol in ED
The Chief Resident, Trauma Fellow or Attending must see the patient within 5 minutes of consult requests by the ED.
h. Any pediatric trauma
patients admitted by the ED to the hospital are
to be seen by the Trauma
Service, who will be notified by the ED.
i. The most frequently used
Trauma Group Pages include:
i.
“Trauma Admission ETA (x many minutes by ground or by air)”
ii.
“Trauma Admission Now”
iii.
“OR Resus ETA (x many minutes by ground or by air)”
iv.
“Trauma Admission Standby”
v.
“Trauma Admission Cancelled”
a. Do not stick needles in
mattresses. There are needle disposal units in the room.
b. Double gloving is suggested.
c.
Universal precautions are to be worn for all patients. This includes
mask, eye protection, and gown. A 1991 study demonstrated a 3% HIV rate and 18%
Hepatitis B rate for all trauma/emergent admissions to UCSD.
(see Appendix
C MIVT Report &
Appendix D Responsibilities of
Trauma Team Members)
a. Daytime resuscitations are
crowded. Doc #1 should ask extraneous people to leave.
b. A “pre-admission game
plan” should be articulated by Doc #1 to the rest of the team.
c.
Doc #1 should articulate patient's plan of diagnostic work up within
first 5 minutes of admission.
d. House staff and med students
should be familiar with the room and all supplies.
e. All Trauma Service
physicians should be comfortable intubating
patients.
f. Techniques/Routines
Everyone should feel comfortable and know how to assist/perform the following at their level of responsibility:
i.
cricothyroidotomy
ii.
chest tube placement/removal
iii.
central line placement
iv.
venous cutdown technique
v.
resuscitative thoracotomy
g. Burn/Pediatric/Elderly (>65 years old) Patients
Unless otherwise specified, all IV fluids will be put immediately on IVACs.
The nurse will need the order for the fluid maintenance rate early in resus (and supplement with IV fluid boluses, as required).
h. Blood alcohol and urine toxicology
is to be sent routinely in all trauma resuscitations.
i. Female patients of
childbearing age who, for a prolonged time frame, are unable to give a good
history (i.e. comatose, depressed LOC, etc.) and lack family to give a good
history, should have a pregnancy screening test sent to the lab.
j. Procedure for Obtaining Blood Clot
i.
When a patient is admitted to the resuscitation room, blood will be
obtained as soon as possible for blood typing. Doc #1 will determine which
blood studies are to be obtained.
(see Appendix E Resuscitation Room Lab
Investigations)
ii.
Prior to patient arrival, the Trauma Tech will hand Doc #3 or 4 the
blood drawing apparatus. Use a betadine swab, NOT ALCOHOL to prep the patient.
iii.
After the blood is drawn for a clot, cap the needle and hand the
apparatus to the trauma tech.
iv.
The patient addressograph stamped labels should be crosschecked with the AKA name on the board at the head of
the bed or with the patient ID band. This crosscheck must be done by the Trauma
Tech who handles the blood sample.
k. Ordering Blood
i.
One person should be delegated to communicate with the Blood Bank. In
most cases this is the Trauma Tech or Circulating Resus Nurse; in OR
resuscitations, it is the Circulating OR Nurse.
ii.
If transfusion is emergently required (whether a clot tube has been
sent or not), the Trauma Fellow or Attending may request blood for emergency
transfusion, specifying:
1. the patient’s name
2. number of units required and
3.
how rapidly they need to be delivered.
For example, “Patient AKA Walrus 42 needs 4 units of blood now.”
iii.
The Blood Bank will release up to 4 units of type O- blood. A labeled
clot specimen should be obtained if at all possible, before administration
of uncrossmatched O- blood.
iv. These 4 units of type O- blood can be obtained only with a signed “Request for Emergency Blood” form, which should be taken to the Blood Bank with an addressograph stamped. DO NOT go to the Blood Bank without this stamped form. (see Appendix F Request for Emergency Blood)
v.
If the patient needs blood immediately, do not specify whether
or not crossmatched, unmatched or type specific blood is needed; this will slow
the time to transfusion. (Based on time constraints, the Blood Bank as per their protocol will release the most appropriate and most compatible blood with the
patient’s blood type.)
vi.
After the first 4 units of O- blood the Blood Bank may release type O+.
(The Blood Bank may provide Type O+ for males
or females of non-childbearing age.)
vii.
Consider ordering 4 units of AB/Type specific plasma if massive
transfusion is a possibility.
viii.
During routine sampling, non-emergent transfusion, or during a resuscitation
that does not require stat blood release, the surgeon can continue to
specify the status of the blood he/she would like “set up” on the
patient (i.e. type and crossmatch or type and
screen).
* As of August 1, 2011, a patient’s ABO/Rh type must be determined twice, on two separately drawn blood specimens in order for patients to receive type specific PRBCs for transfusion at UC San Diego Health System. This policy does not apply to patients requiring emergent transfusions.
i.
When it is anticipated that more than 10 units of packed red blood
cells (PRBCs) will be used for a patient, activate the Massive Transfusion
Protocol by calling the Blood Bank (x35640).
ii.
The Blood Bank will then mobilize 45 units each of PRBCs and plasma,
and 4-6 units of apheresis platelets ASAP.
·
The initial 4 units of RBCs may be O- along with 4 units of AB plasma.
·
Immediately following this, 6 units of RBCs, 6 units of plasma, and 1
apheresis platelet unit will be supplied, followed by batches of 10 RBCs, 10
plasma, and 1-2 platelets.
·
Type-specific blood will be initiated as soon as possible and depends on the availability of a second
blood specimen for ABO/Rh
confirmation.
·
If necessary, in order to provide sufficient blood without
delay, the decision to switch blood types (eg, to O for type B; A or O for type AB) will be made by the Blood Bank.
iii.
In the OR, the Trauma Service should plan with Anesthesia to
continue to communicate with Blood Bank to stay 10 units ahead with both
RBCs and FFP.
iv.
Send “Request for Emergency Blood” to Blood Bank.
v.
Obtain a clot to send to Blood Bank even if the heart is empty (i.e.
from a clot in a basin or from a hemothorax).
vi.
It is the Trauma Fellow/Attending’s and/or Senior
Resident’s responsibility to determine when FFP, platelets,
cryoprecipitate, etc., will be ordered as part
of the Massive Transfusion Protocol.
vii.
For patients presenting within 3 hours of injury, consideration
should be given to the administration of tranexamic
acid (loading dose of 1g IV over 10 minutes followed by an infusion of 1g
IV over the next 8 hours).
viii.
When the patient is stabilized, consider calling the Blood Bank to
cancel the Massive Transfusion Protocol.
ix.
If the patient is pronounced, call the Blood Bank immediately to cancel
the Massive Transfusion Protocol.
l. Talk to patients in the
resus room and explain the rationale for what is being done and why. This is paarticularly important prior to
performing rectal exams, inserting Foley catheters, and femoral artery punctures.
m. Talk to families early. This
role is assigned to either Doc #1 or Doc #2.
n. Sutures are used to provide
definitive repair of scalp wounds. Do not staple scalp wounds.
o.
All medication reconciliation must be performed in EPIC on admission.
p.
A “debriefing” with the trauma resus RNs should be
performed at the end of the resus to
coordinate all orders/meds. These should all be marked on the appropriate order
forms. Doc #1 is not to leave the resus room prior to this.
a. Criteria for OR Resus (Direct transport to OR #11)
i.
Penetrating trauma with hypotension
ii.
Witnessed traumatic cardiac arrest
iii.
Hypotensive patients who are unresponsive to fluid challenges in the prehospital setting. (i.e. <
90mmHg systolic BP)
iv.
Major external hemorrhage - uncontrolled (i.e. amputation above knee or
elbow)
v.
Direct injury to neck with serious airway compromise
b. While still en route to the
hospital, do not change patient's place of destination at the last minute. A
resuscitation nurse or senior trauma physician can call an OR Resus as long as
the patient is more than 5 minutes ETA. Once the decision has been made, do
not change the decision. There is often
not enough time to move either the trauma team or paramedics to another
destination. In addition, the doctor
escorting the patient from the ED door will not be aware of the new destination.
a. Only the
Trauma Fellow/Attending can place the Trauma Center on Trauma Bypass. Trauma Bypass means that the
prehospital personnel (MICN radio nurse, paramedics, Base Hospital physician)
will divert injured major trauma victims from UCSDMC to other trauma hospitals
in San Diego County.
b. Trauma Bypass is different from other county bypass
reasons/statuses (i.e. ED saturation, Hospital full, or No ICU beds). Even if
the hospital is on ED saturation, Hospital full or No ICU beds bypass status,
this does not mean we are automatically on Trauma Bypass.
c. On occasion,
Children’s Hospital Trauma Center will have no ICU beds. When this occurs
they will call the UCSDMC Trauma Surgeon on call, and notify him/her that the
Pediatric Age Specific bypass plan is enacted. Therefore, ALL pediatric patients
10 to 14 years of age will be sent to UCSDMC Trauma Center until
Children’s Trauma Center is off bypass.
a. Wet readings by Radiology
should be documented as such by the Trauma Service in the progress notes - especially
since subsequent care is based on these readings. If
final readings
by
Attending Radiologists are different
from wet readings, the
radiologist will immediately notify the Trauma Fellow or Attending.
b. Patients admitted as a
transfer with outside CT scans or x-rays should have their films uploaded into
the PACS system. A green request form must be filled out in order to have
images uploaded to PACS. (see Appendix G Imaging Request)
c. Final reads must be obtained
from the transferring facility. However, an “unofficial” read of
imaging studies may be obtained if an order is written and Radiology notified.
d. A member of the house staff
(or NP/PA) must accompany each trauma patient to the CT scanner.
e. Use the American Association
for the Surgery of Trauma-Organ Injury Scale (AAST- OIS) for documentation of
all intra-abdominal injuries, wherever possible. These may be found at the
following website: http://aast.org/Library/TraumaTools.aspx
(see Trauma
Protocols & Guidelines Cervical and Thoracolumbar Spinal
Precautions; also,
Appendix O Trauma
Protocol Algorithms>C-Spine Evaluable/Inevaluable)
a. Normal trauma routine for clearing
the C-spine includes 3-4 plain radiographic
views or CT of the C-spine, combined with clinical exam/clearance
of the C-spine.
b. Any patient
with:
i.
midline cervical pain or tenderness
ii.
a distracting injury or competing pain
iii.
intoxication (any intoxicating substance)
iv.
any head injury or impaired
level of consciousness
v.
focal neurological deficit
SHOULD NOT
undergo attempted clinical exam/clearance until sensorium is cleared (usually the next
morning).
c. A C-spine CT is the preferred
imaging modality if the patient is scheduled to undergo another type off CT examination. In this subgroup, a
cross table lateral C-spine plain film is mandatory
prior to moving the patient to the CT scanner.
d. Patients with any spinal
fracture should have a radiologic exam of the entire spine.
e. “C-spine
precautions” includes:
i.
bedrest
ii.
head flat
iii.
C-spine immobilization in a rigid cervical collar (Philadelphia collar
or Miami J) at all times
iv.
transport flat on a gurney
In some low risk patients, after T&L spines have been cleared, the senior physician may use his/her judgment and write the C-spine precautions order to include “HOB may be up 30 degrees.”
f. “T-L spine precautions”
i.
bed flat (patient may be in slight reverse Trendelenburg)
g. C-spine Clearance
Clinically clearing the C-spine involves performing a physical examination to rule out midline pain or tenderness with palpation. If the patient denies midline pain and tenderness with palpation, the anterior half of the collar may then be removed. The patient should then be given clear instructions to slowly move his/her head from side to side (without assistance) and then back to front and to stop at any time if he/she experiences any pain/discomfort.
h. Patients who are intubated
for a prolonged period of time or are
unable/incapable of having their C-spine cleared clinically, should undergo MRI
of the C-spine within the first 10 days of
admission to rule out ligamentous injury. If the MRI does not demonstrate signs
of ligamentous injury, the C collar may be removed.
i. An order and progress note (documenting that the
patient’s C-spine has been both radiographically and clinically cleared) must be written in order to clarify that
the patient no longer requires C-spine precautions.
j. Any patient with complaints
of midline pain or tenderness of the C-spine should be kept in a Philadelphia
collar (or changed to a soft collar) regardless of their radiographic exam
results. The patient should be instructed to wear the collar until he/she
returns to Trauma Clinic.
k. Occasionally, the spine
surgery service (either Neurosurgery or Orthopaedics) may request patient guiided flexion/ extension
(“flex/ex”) views of the C-spine.
i.
The correct procedure for obtaining flex/ex views of the C-spine entails that:
1. a physician from the
requesting service must be present in the
radiology suite to supervise patient movement during the study. (Include
in the order and specify service and doctor with pager #.)
2. the patient should be
allowed to move his/her own neck in
flexion/extension exams. If the patient experiences pain or tenderness, the
exam should be stopped.
l. Patients who require a
Philadelphia collar for extended periods of time are at risk for skin
breakdown. These patients may have a Miami J collar placed in lieu of a Philly
collar.
(see Trauma
Protocols & Guidelines VTE Prophylaxis Protocol)
a. Venodynes are not used if a
patient is only admitted for an overnight admission.
b. Venodynes should be ordered
separately from ordering the Trauma Duplex
Protocol.
c. Trauma Duplex Protocol
i.
The Trauma Routine Duplex Protocol should only be ordered for
patients with High Risk or Extreme Risk.
ii.
The patient will receive an initial screening Duplex in the first 48
hours of admission. A second will be done during the first week of admission by
the Ultrasound Lab; serial duplexes will be done weekly thereafter. The results
of the duplexes can be found in Epic under “Imaging”.
c. Patients should receive
appropriate pharmacologic DVT/PE prophylaxis according to protocol.
d. Patients with IVC filters
still require Venodynes and weekly Duplex screening.
e. When immobile patients are
transferred to nursing homes, SNF, extended care facilities, etc., the discharge
summary/orders should include recommendations for
DVT prophylaxis-either low molecular weight heparin (i.e. Lovenox) or
unfractionated heparin.
a.
No extubations are to be performed after
1900 unless a Trauma Fellow or
Attending agrees and is present.
b.
No extubations are to be performed in
patients with a known history of a “difficult airway” or
“difficult intubation” unless
a Trauma Fellow/Attending or Critical Care Attending agrees and is present.
(Includes patients who are status post anesthesia with difficult
airway/intubation and/or significant soft tissue neck injury.)
c.
No extubations are to be performed in
patients status postoperative neck surgery
(spine surgery cases included) unless a
Trauma Fellow/Attending or Critical Care Attending agrees and is present.
a. The "morning
after" head to toe physical re-examination must be done and documented by
a physician or NP/PA. (see Appendix H Tertiary
Survey of Trauma Patient)
a. Patients with low
hematocrits (<30%) on the medical-surgical ward who can tolerate oral intake
should receive ferrous sulfate 325mg po tid and docusate sodium 50- 500mg po
divided in 1-4 doses while in hospital.
b.
If eating normally at the time of discharge, patients should be
instructed to take over the counter ferrous
sulfate.
(see Trauma
Protocols & Guidelines Reporting Deaths, Complications, and
M&M)
a. A death packet must be filled
out AND a discharge/death dictation must be performed for every patient who
dies in the medical center.
b. All trauma deaths in the OR
are medical examiner’s cases. It is important to note the time of death and which surgeon
pronounced the patient. Leave all lines/tubes in place.
c. Notify the Medical Examiner’s Office (858-694-2895) of any death
based on criteria in death packet
d. Until a patient is declared brain dead, the Trauma Service writes
all orders on patient; LifeSharing is an assistive service only.
a. Every morning, the Chief or
Senior Resident should review all patients who could be potentially ready for
discharge that day. They should discuss with the Trauma Fellow/Attending
any details that might be needed for discharge and ensure that all such
concerns are addressed so as to facilitate an early, prompt, and safe discharge.
b. Once the approval for
discharge is given, the Senior Resident should contact the Junior Resident to get
the process moving. Case Managers should also be notified so that they may
assist in the process.
c. The resident should also
attempt to identify any patient who might be able to be discharged the
following day and discuss these patients with the Fellow/Attending.
d. Discharge orders should be
written by 10:00 AM so that the patient leaves the hospital by at 2:00 PM.
e. All labs and x-ray orders
are to have the words “PENDING DISCHARGE” if the patient’s dischharge is dependent upon the results of
these tests.
a. Appropriate trauma patients
should be scheduled for at least one Trauma
Clinic appointment upon discharge.
b. Criteria for clinic appointments
i.
Patients with NO injuries DO NOT require Trauma Clinic follow-up. (Can
suggest follow-up with PMD)
ii.
If the Trauma Service placed sutures/staples, follow-up in Trauma
Clinic in 7- 14 days for removal. Alternatively, may follow-up with PMD for removal.
iii.
If the Trauma Service is caring for wound(s), follow-up in Trauma
Clinic in 1 week for a wound check.
iv.
If patient had a chest tube inserted, follow-up in Trauma Clinic in 1
week for CXR.
v.
If patient sustained a minor isolated system injury and no other Trauma
Service issues, follow-up should be with the appropriate clinic (Ortho, Neuro,
Plastics, HNS).
These patients DO NOT require followup in Trauma Clinic.
vi.
If the patient is a Kaiser patient or on active military duty,
follow-up should be with Kaiser or the Naval Medical Center San Diego (Balboa),
respectively. These patients do not require follow-up in the Trauma Clinic.
vii.
If the patient had a retrievable IVC filter placed, follow-up in Trauma
Clinic in 4-6 weeks.
viii.
Any patient that underwent an interventional procedure, including placement of a retrievable IVC filter,
and all patients with any Anatomic Injury Severity score ≥3, should have
follow-up arranged in Trauma Clinic.
ix.
Patients currently enrolled in clinical studies should also have
follow-up arranged in the Trauma Clinic.
c. For discharges on
Monday/Tuesday→Appointment for same week
Friday.
d. For discharges on Wednesday
or later→Appointment for next week Friday.
e. Friday Trauma Clinic is run
by the Trauma NP/PAs. However, Trauma residents may be required to attend if
the clinic is particularly busy. Resident notes must be signed by the attending.
Protocol:
Doc #1 is responsible for determining the necessity of obtaining an airway by means of intubation or cricothyroidotomy after discussion with the Trauma Fellow/Attending.
Anesthesia can be paged by accessing the code blue page beeper for Anesthesia (x2622) and should respond within five minutes.
The senior ED resident will be present with the trauma team prior to the patient’s arrival and will page his ED attending for the procedure.
Procedure:
a. When a trauma patient
arrives, Doc #1 in conjunction with the Trauma Fellow/Attending is in charge of
the patient’s airway including decisions for intubation and adjunctivve management. Should Doc #1 ask for the
patient to be intubated, either the ED
resident with ED attending backup or Anesthesia
covering the code pager (x2622) will proceed.
b. ED residents will be
scheduled for doing the resus suite intubations only when they are Doc #1 and
provided a Trauma Attending is present. The ED attending will be paged stat to
the resus suite to supervise the ED resident. The Trauma Attending will be at
the bedside supervising patient management and decision making.
c. If Anesthesia is to
intubate, the Anesthesia code pager is paged. This code beeper is carried by the in-hospital Anesthesia
resident or attending 24 hours a day. As a backup in the event that the
Anesthesia code pager fails to get a response, the Anesthesia floor walker may
be accessed by calling the OR front desk (x36040).
d. Rapid Sequence Intubation Procedure:
(see Appendix
I Rapid Sequence Intubation)
i.
All patients should be considered to require C-spine precautions and to have a full stomach. Manual C-spine precautions will be held
by Doc #2.
ii.
Cricoid pressure will be held until the tube placement is confirmed and the cuff inflated. The most senior
surgeon available (usually the Trauma Attending/Fellow) will hold cricoid pressure.
iii.
Placement of the O2 sat
monitor, EKG leads, and suction availability will be a priority for nursing.
iv.
A Trauma Attending will be at the bedside for all intubations and is in charge of the intubation procedure.
v.
In order to standardize stocked medications, the following will be used for intubation
in the resus suite:
1. Etomidate
2. Succinylcholine or Rocuronium
These are available as an RSI kit in the Pyxis.
vi.
Oral intubation attempts should be limited to a total of 3. (For example, in the case of the ED rresident intubating, he can attempt
twice and his attending could attempt once.)
vii.
When the intubator finds that the patient has a “difficult
airway” (i.e. anterior airway or unable to have a good view due to
secretions, blood, or edema, he/she should tell
the team immediately. The resus nurse will respond by having the
cricothyroidotomy set out and available.
viii.
The Trauma Attending will make the decision as to whether to do a surgical airway/cricothyroidotomy.
ix.
After intubation, physical exam in conjunction with a
disposable CO2 detector
and/or ETCO2 monitor will
be used to confirm the adequacy of tube placement. Cricoid pressure must be maintained until confirmation of
appropriate tube placement has been verified.
An NG tube and Foley catheter should be placed followed by a CXR to verify ETT and NG tube placement.
Repositioning of the ETT mandates confirmation of position radiographically prior to leaving the resuscitation room.
a. Only an R3 or above can
place chest tubes in mechanically ventilated
patients.
b. All other chest tubes are to
be supervised by an R3 or above.
c. Conscious sedation may be
administered to awake patients.
d. Chest tube removal is a
2-person procedure requiring the presence of either an NP/PA or R3 and
a. Residents must receive
appropriate training before placing central
lines independently.
i.
Learn ICU (SCCM)
1. Self-pace Course UCSD registration:
http://sccmwww.sccm.org/LMS/NewUser.aspx?progid=886
2. Pulmonary Artery Catheter
Education Project (PACEP) http://www.pacep.org/
ii.
SICU Central Line Course http://trauma.ucsd.edu/Default.aspx?tabid=184
iii.
Ultrasound Course http://trauma.ucsd.edu/Default.aspx?tabid=175 username: ultrasound password: UltraSound2008
The following physiological parameters should be maintained as part of goal-directed traumatic brain injury (TBI) treatment.
|
Primary Parameters |
Secondary Parameters |
|
Pulse Ox ≥90% ICP
<20 mmHg |
CPP ≥ 60 mmHg |
|
PaO2 ≥100 mmHg Temp 36.0-38.3°C |
PbtO2 ≥ 15 mmHg |
|
PaCO2 35-40mmHg Glucose
≤ 160 mg/dL |
|
|
SBP ≥100 mmHg INR≤ 1.3 |
|
|
pH 7.35-7.45 |
|
1. Airway Management
i. Patients with a GCS ≤
8 should be intubated for airway protection
Patients with a Glasgow Coma Score (GCS) equal to or less than eight, and those unable to protect their airway, should undergo endotracheal intubation with in-line cervical spine immobilization. Rapid sequence intubation (RSI) is the preferred method. Intubation should be considered for GCS ≤ 10. An attempt to contact the neurosurgery team before intubation is preferable as it will allow for evaluation of the patient’s neurological status prior to the administration of sedation and paralysis.
ii. Sedative and analgesic choices
should include short acting agents through the initial resuscitation, as temporal
assessment of neurological status is critical. In general the following agents
are recommended:
·
Etomidate - sedation for induction (RSI)
·
Succinylcholine - paralytic for induction (RSI)
·
Propofol - maintenance of sedation,
prevention of agitation. Propofol is
not an induction agent and is to be discontinued if its use is causing
persistent hypotension requiring vasopressor
agents.
·
Benzodiazepines- (i.e. midazolam or lorazepam)
can be utilized as an initial or substitute sedative agent for propofol.
2. Oxygenation/Ventilation
i. Avoidance of hypoxia
Efforts should be made to avoid hypoxia at all times.
·
Patients with TBI should have pulse oximetry maintained at a SaO2 ≥90% and an attempt for PaO2 ≥ 100 mmHg.
ii. Ventilation
Hyperventilation should be intensively monitored during the initial resuscitation.
· The target PaCO2 is 35-40 mmHg.
An ETCO2 monitor and serial ABGs should
be used as needed should be used to prevent profound hypocarbia/ hypercarbia.
·
Therapeutic hyperventilation may be necessary for brief periods when
there is acute neurological
deterioration that coincides with a cerebral herniation syndrome or for
refractory elevations in ICP (see Section III on management of ICP)
3. Blood Pressure, Volume
Resuscitation, Anemia, and Coagulopathy
i. Blood Pressure
Systolic blood pressure (SBP) and mean arterial pressure (MAP) readings should be recorded from a functioning arterial line when present and from the non-invasive blood pressure (NIBP) cuff when an arterial line is not present or presumed inaccurate.
· Any patient requiring with
intracranial hypertension must have an arterial
line for the purposes of both hemodynamic monitoring and blood draws. A
systolic blood pressure (SBP) should be kept between 100 mmHg and 180 mmHg.
·
Recognize that lower blood pressures can represent a
“relative” hypotensive
state in TBI patients (especially with elevated ICP)
·
Normal Saline, PRBCs and plasma (when needed) should be used as the
initial method of maintaining euvolemia to achieve the target blood pressure.
· Assessment for
implementation of vasopressors should be considered for treatment of refracttory hypotension only after
appropriate volume resuscitation. Vasopressors or Inotropes including
Phenylephrine (Neosynephrine), Levophed, Epinephrine, Dobutamine, and
Vasopressin should not be used to
counteract the hemodynamic effects of propofol.
ii. Euvolemia
The primary target is euvolemia through resuscitation. In many cases, a central venous pressure (CVP) will need to be obtained. CVP or other types of invasive monitoring are mandatory in patients with severe TBI requiring ventriculostomy, intubation or in patients with hypotensive events requiring optimization of volume status.
iii. Coagulation
Coagulation panels should be followed closely, particularly in patients on anti- coagulation medications or with pre-existing bleeding dyscrasias. It is acceptable to use a stricter transfusion criteria, such as a platelet count of ≥ 80 x 103/mm3.
·
FFP, Vitamin K, prothrombin complex concentrate, Factor VII, or DDAVP should be administered, as
clinically indicated, in order to correct coagulopathy irrespective of need for
surgical intervention.
· INR and platelet count
should be corrected in anticipation of operative intervention or bedside procedures such as placement
of ventriculostomy or
other ICP monitors.
4. Imaging
i. All patients with suspected
TBI (i.e. LOC, significant mechanism) must undergo urgent CT of the brain (CTH)
during the initial resuscitation barring emergent operative management. Timing of
repeat imaging is suggested below. MRI brain scans should be utilized for
assessment of ischemic CVA, DAI, tumor assessment or per research protocols.
MRI can also be used to help determine potential for neurologic viability
particularly in patients with a persistent vegetative state.
All patients with signs and symptoms of increased intracranial pressure (ICP) and/or GCS ≤ 8 should receive a ventriculostomy (primarily) or other form of ICP monitoring.
ICP should be monitored in patients with TBI if the GCS is ≤ 8 following initial resuscitation and the admission CT scan of the brain is abnormal (hematomas, contusions, edema or compressed cisterns). All patients with suspected increased intracranial pressure and GCS ≤ 8 should receive a ventriculostomy as the primary ICP monitor unless the clinical situation mandates a sub-dural bolt device.
Contraindications for ventriculostomy include 1) coagulopathy 2) mass lesion with mass effect at the site of the ventriculostomy site.
1. ICP monitoring should
additionally be considered for those patients with a normal admission CT scan
of the brain if two or more of the following criteria are met:
·
age > 40 y/o
·
unilateral or bilateral motor posturing
·
documented episode of hypotension (SBP
<90mmHg)
In addition, ICP monitoring should be highly considered in all patients undergoing emergent surgical procedures (orthopedic repair, etc) in whom a moderate to severe brain injury is suspected (GCS 3-12) to guide appropriate intraoperative CPP management.
i.
Increased ICP is defined as ≥ 20
mmHg.
ii.
Prophylactic antibiotic use, and routine surveillance cultures for ICP
monitors are not recommended, but
its use is under the discretion of the trauma and neurosurgical teams.
iii. Cerebral Perfusion Pressure
(CPP) of ≥60mmHg should be targeted. Neosynephrine infusion or other
vasoactive adjuncts may be used to improve the CPP in the euvolemic,
resuscitated patient.
(see Appendix O Trauma Protocol Algorithms>Intracranial Hypertension) Treatment for
intracranial hypertension should be initiated when the ICP ≥ 20 mmHg.
A leveled algorithm will be used for increased ICP. Each level represents increased
levels of intensity for the treatment of elevated ICP, and patients should be initiated in Level I, then staged through Level 3. If the treatments in a given Level have not sufficiently lowered the ICP within 20 minutes of implementation, then advancement to the next Level should be promptly initiated.
![]()
·
Head of patient’s bed to be placed at ≥ 30 degrees.
·
Sedation and analgesia using recommended agents (propofol,
fentanyl, and versed) in intubated patients. Pain relief and sedation are
appropriate initial modalities for treatment of intracranial hypertension.
·
Ventriculostomy – extra ventricular
drain (EVD) is the preferred method of ICP monitoring. Other forms of ICP
monitoring i.e. bolt placement, should be used when EVD is not technically or
physiologically feasible.
·
Mannitol – 0.25-1.0g/kg; IV
bolus x 1 dose for lateralizing lesions or blown pupil with impending herniation.
![]()
·
Hyperosmolar therapy
o
Mannitol:
intermittent boluses of mannitol (0.25 - 1gm/kg body weight) should be
administered. Attention must be placed upon maintaining a euvolemic state when osmotic diuresis is instituted with
mannitol. The serum sodium and osmolality must be assessed frequently (every
6hrs) and additional doses should be held if the serum osmolality exceeds
320mOsm/L. Maintain a serum OSM <320mOsm with targeted serum Na+ of
<160mEq/L.
o
Hypertonic
saline: Serum sodium and osmolality must be assessed frequently (every
6 hr) and additional doses should be held if the serum sodium exceeds 160mEq/L.
·
Neuromuscular paralysis: pharmacologic paralysis
with a continuous infusion of a
neuromuscular blocking agent should be considered if the above measures fail to
adequately lower the ICP and restore CPP. The infusion should be titrated to
maintain at least two twitches (out of a train of four) using a peripheral
nerve stimulator. Adequate sedation must be utilized if pharmacologic paralysis
is employed and can be confirmed with BIS monitoring.
![]()
![]()
·
Patient with Level 3 intracranial hypertension should undergo imaging
to determine the presence of
cerebral sinus thrombosis.
·
Decompressive
hemi-craniectomy or bilateral craniectomy should only be performed if Levels 1 and 2
are not sufficient.
·
Barbiturate coma: an induced coma is an option
for those patients who have failed
to respond to aggressive measures to control malignant ICP including
decompressive craniectomy. The use of BIS monitoring or equivalent is needed for assurance of adequate sedation and
coma. Side effects include sudden hemodynamic collapse and a high incidence of
pneumonia. Appropriate volume resuscitation and hemodynamic monitoring is
mandatory. Utilizing vasopressor therapy may be warranted.
![]()
1. Antiseizure Prophylaxis
Phenytoin has efficacy in preventing early post-traumatic seizures in patients with traumatic brain injury. Keppra (Levetiracetam) is the preferred anti-seizure medication given its lower side-effect profile and less need for tight monitoring of serum levels.
Medication should be considered to be discontinued after 7 days if no seizure activity occurs, however, a longer duration should be considered in patients with temporal lobe injuries.
2. Stress Ulcer Prophylaxis
Patients with significant traumatic brain injury requiring mechanical ventilation as well as those with coagulopathies or a history of gastric or duodenal ulcers should receive stress ulcer prophylaxis with an intravenous H-2 blocking agent or proton pump inhibitor.
3. Deep Venous Thrombosis (DVT) Prophylaxis
All patients with significant traumatic brain injury requiring mechanical ventilation and sedation should receive DVT prophylaxis in the form of sequential compression stockings upon admission. Subcutaneous low molecular weight heparin (Lovenox) may also be initiated within 24 hours of admission, unless contraindicated due to evidence of bleeding, need for surgery, or indwelling intracranial monitor.
4.
Early Tracheostomy
Tracheostomy is recommended in ventilator dependent patients to reduce total days of ET intubation. This is at the discretion of the trauma and neurosurgery service.
5. Nutritional Support
Nutritional support should be initiated via enteral route within 48 hours post injury. Frequent assessment of residual volumes of gastric nutrition should be performed, as patients with TBI frequently do not tolerate intragastric feeding, and are at risk for emesis and aspiration. Efforts should be made to obtain small bowel feeding access (i.e. Cortrak).
1.
Epidural Hematomas
An epidural hematoma (EDH) of greater than 30 cm3 should be surgically removed regardless of GCS. Continued non-operative management should be considered in posterior EDH of venous origin. Patients with an acute EDH, GCS <9, and anisocoria should undergo emergent EDH evacuation. EDH of less than 5 mm midline shift in patients with GCS >8 and no focal neurological deficit can be closely monitored in an ICU with serial CT scans. Judicious use of narcotics and sedatives is important as not to alter the neurologic exam. Repeat CTH should be within 4-6 if patient are to be managed non-operatively.
2.
Acute Subdural Hematomas
Acute subdural hematomas (SDH) with a thickness of greater than 10 mm or 5 mm of midline shift on CT scan should be evacuated emergently regardless of the GCS (clinical judgment should be used in patients with significant underlying atrophy). A SDH less than 10 mm thickness and less than 5 mm midline shift should be evacuated emergently if the patient has: GCS decrease by 2 points, asymmetric pupils or fixed pupils, or ICP > 20 mmHg. Repeat CTH should be within 4-6 if patient are to be managed non-operatively.
3.
Subarachnoid Hemorrhage
All patients with GCS <9 and SAH should have ICP monitoring with an EVD as the preferred monitoring of choice. Repeat CTH should be within 4-6 if patient are to be managed non-operatively.
4. Parenchymal Lesions
Intraparenchymal
hemorrhage (IPH) causing progressive neurological deterioration, medically
refractory ICP elevations, or significant mass effect should be emergently
evacuated. Frontal or temporal contusions with IPH >3.0 cm3 and >5 mm shift or cistern compression in patients with GCS 6-8
should be evacuated. Normal ICP should
not preclude operative evacuation since herniation can occur without
intracranial hypertension. Repeat CTH should be within 4-6 if patient are
to be managed non- operatively.
5.
Diffuse Medically-Refractory Cerebral Edema and Elevated ICP
Decompressive craniectomy for refractory elevated ICP (unilateral or bilateral) within 48 hours of injury should be considered. Ultra early decompressive craniectomy prior to ICP monitoring is not recommended, unless surgery is performed for a mass occupying lesion (hematoma) and the bone flap is not replaced.
6.
Depressed Skull Fractures
Open skull fractures depressed greater than the thickness of the inner and outer table should undergo operative management. Referable symptoms attributed to the fracture site are an absolute indication for operative management. Open depressed fractures that are less than 1cm depressed and have no dural penetration, no significant intracranial hematomas, no frontal sinus involvement, no gross cosmetic deformity, no pneumocephalus, and/or no gross wound contamination may be managed non- operatively. All open skull fractures should be treated with prophylactic IV antibiotics.
(see Appendix
O Trauma Protocol Algorithms>Anticoagulation-No CHI/CHI)
The following procedure applies for all injured patients admitted on anticoagulants:
a. Obtain appropriate labs
i.
PT/PTT/INR
ii.
Plavix assay
b. Head injury, with CT
findings or loss of consciousness or with significant facial trauma or head/scalp area trauma:
i.
All anticoagulants held
ii.
Repeat CT scan within 6 hours of admission
iii.
Consult Neurosurgery
iv.
Reversal Plan
1. Admit to ICU
2. Reversal of anticoagulation
with FFP to INR of 1.3 or less
3. If on clopidogrel (Plavix), consider:
·
platelet transfusion
·
DDAVP
4. If head CT abnormal or INR
is ³ 5 consider the following:
·
Vitamin K 10mg IV over 30 min*
·
Profilnine 25-50 IU/kg IV (range 25-100IU/kg); may repeat as necessary.
a.
Follow INR, PT, PTT
b.
If INR increases after initial reversal
i.
Continue q6h labs and FFP prn
ii.
Consider repeat dose of Profilnine
2. If repeat head CT is negative, discharge from closed head injury viewpoint and restart anticoagulation
*Care should be taken to
AVOID administration of IV Vitamin K to patients receiving anticoagulation in
the setting of a known mechanical valve due to the risk of valve thrombosis.
c.
Significant soft tissue injury (long bone/pelvic fracture with soft
tissue damage), including chest,
abdomen, and retroperitoneum:
i.
Admission to IMU or ICU
ii.
Hold anticoagulants
iii.
Reverse anticoagulation (b. iv. Reversal Plan)
iv.
Follow hematocrits/hemoglobins
v.
Repeat CXR for chest injury
vi.
Consider repeating abdominal/chest CT in 12-18 hours if suspicious for retroperitoneal
bleeding or parenchymal injuries
d.
Patients without significant injury, without loss of consciousness, and
not requiring surgery or invasive procedures
i.
Hold anticoagulants
ii.
These patients do not require reversal.
Protocol:
In all cases of trauma team activations and admissions, spinal injury will be assumed
until proven
otherwise in
all patients, including those with:
a. neurologic spinal or CNS deficits
b. spinal pain and/or tenderness
c. significant mechanism of
injury, including (as examples):
i.
two or more proximal long bone fractures
ii.
evidence of high impact
iii.
victim ejection
iv.
comatose state secondary to head trauma or those patients requiring induced
pharmacologic neuromuscular blockade
Patients arriving with suspected spinal injury and immobilization by a rigid cervical orthosis (i.e. Philadelphia collar) and/or spine board will not have them removed until appropriate clinical radiographic evaluations are obtained. If the patient is not immobilized upon presentation, appropriate immobilization will be applied.
Procedure:
a. Patients admitted with
suspected spinal injury or high index of suspicion, due to mechanism of injury or
by physical exam, will have rigid cervical collars applied and a spinal board
placed. These will not be removed until radiographic and clinical evaluations
are completed. Special consideration regarding pain perception should be given
to the intoxicated or drugged patient and to the patient with
“competing” pain.
b. Any patient with a high
index of suspicion of spinal injury who is admitted via prehospital Emergency
Medical System personnel, and does not have spinal precautions in place, will
be audited by the Trauma Coordinator and forwarded to the Base Hospital Coordinator.
c. A complete neurologic
examination including motor/sensory/reflexes and rectal examination will be
performed and documented. Presence or absence of the bulbocavernosus reflex
will be noted.
d. If possible, obtaining
spinal x-rays and determination of the presence or absence of injury should be
done prior to any surgical procedure. Should an emergency condition preclude
complete evaluation, spinal immobilization will continue until evaluation is completed.
e. Normal trauma routine for
clearing C-spine includes 3-4 radiographic x-ray views or CT of the C-spine
initially, combined with clinical exam of the C-spine. A patient with
competing pain, and intoxicating substance on board or any head injury should not have the clinical motion exams attempted until sensorium is cleared (usually the next morning).
f. Patients with any spinal
fracture should have a radiologic exam of the entire spine.
g. If a patient is undergoing a
CT scan for evaluation of another injury, a CT C-spine should be obtained to
rule out an injury. If not, appropriate cervical spine x-rays include a lateral
(which is taken first, and has priority over other views,) A/P and open-mouth
view. A/P and lateral of thoracic and lumber spine will be obtained when
indicated. Lateral cervical x-rays
must visualize C7. Swimmers views
will be obtained where necessary, except in patients with high risk or severe pain.
h. Cervical spine precautions
for the Division of Trauma includes:
i.
bedrest
ii.
head flat
iii.
C-spine immobilization in a rigid cervical collar (Philadelphia collar
or Miami J) at all times
iv.
transport flat on a gurney
In some low risk patients, after T&L spines have been cleared, the senior physician may use his/her judgment and write the C-spine precautions order to include “HOB may be up 30 degrees.”
i. Physician’s orders
will reflect cervical spine precautions as follows:
i.
Full Spine Precautions
CTL spine injury has not been cleared or an injury has been identified:
1. patient requires rigid
cervical collar at all times
2. full log roll when moving
the patient
3. patient may not be placed on
an air fluidized or air loss specialty bed
4. mattress to remain flat at
all times (reverse Trendelenburg acceptable)
5. bedrest only
ii.
Partial Spine Precautions
Cervical spine
has been cleared radiographically but patient
is unable to cooperate with a physical exam and has a low probability of
ligamentous injury:
1. T & L spines are cleared
2. patient should wear a rigid
cervical collar at all times
3. bed to remain flat at all
times (reverse Trendelenburg OK)
Trauma resident may use judgment and write order for the HOB to be elevated up to 30° in low risk patients.
iii.
CTL Spines Cleared
Patient may be mobilized as appropriate
j. Clinically clearing the
C-spine includes examining the patient for midline pain or tenderness with
palpation. If midline pain or tenderness is absent on examination, the patient
should be instructed to slowly move his head side to side (without assistance)
then to the back and then to the front and to
stop at any time if he has any pain.
k. After negative plain films
and flexion extension films, if a patient complains of cervical pain or soreneess, they should be kept in a
Philadelphia collar or Miami J and be seen in
clinic.
l. Discontinuing cervical spine
precautions will be documented in the physician’s orders and progress
m. Any patient without a
C-spine clearance order and/or progress note will have reinstitution of tthe rigid collar.
a. Patient Groups
i.
Low Risk
No risk factors
ii.
High Risk
Presence of >1 of following:
1. likelihood of bedrest >3 days,
head injury, spine or pelvic fracture, lower extremity fracture
2. laparotomy, thoracotomy, or laparoscopy
3. co-morbid risk factors
including history of prior DVT or PE, obesity, known sepsis, malignancy,
hypercoagulable state, pregnancy
iii.
Extreme Risk
Presence of >1 of following:
1. severe head injury with
therapeutic paralysis and aggressive ICP control
>5-7 days
2. spinal fracture with para-
or quadriplegia
3. unstable pelvic fracture
with bedrest >6 weeks
4. multiple lower extremity fractures
5. patients in High Risk group
where usual measures cannot be employed
b. Screening Measures
i.
Low Risk
No routine screening
ii.
High Risk
Patient screening with venous duplex 2 times in 1st week, then weekly by the Radiology Lab. If patient needs a study prior to placing Venodynes, call Radiology Department Duplex Lab. If they are not available on weekends, call IPG technician.
iii.
Extreme Risk
Patients with no IVC filter will be screened as the High Risk patients but with 2 duplex studies in the first week.
c. Prophylactic Measures
i.
Low Risk
1. mandatory ambulation in 1st 24-36 hours
2. in-bed mobility and lower
extremity exercises
3. NO pneumatic hose or anti-coagulation
ii.
High Risk
1. bilateral lower extremity
pneumatic hose and subcutaneous low molecular weight heparin (i.e.
Lovenox 30 mg SQ bid)
iii.
Extreme Risk
1. Severe head injury
· Head injury requiring
therapeutic paralysis for > 5-7 days combined with lower extremity or pelvic
fracture will receive prophylactic IVC filter placed after consensus between Neurosurgery
and Trauma at the earliest time felt to be safe from the view of head injury
management.
· Isolated head injury
requiring therapeutic paralysis for > 5-7 days will be considered for
prophylactic IVC filter unless strong contraindications exist including young
age, likelihood of future pregnancy, feasibility of anticoagulation or patient
preference. IVC filter placed after consensus between Neurosurgery and Trauma
as above.
· Prophylactic anticoagulation
will be used if not contraindicated.
·
Continue pneumatic compression hose in all patients unless
therapeutically anticoagulated.
2. Spinal cord injury
· Spinal cord
injury combined with lower extremity or pelvic
fractures and isolated spinal cord injuries will receive prophylactic IVC
filter placed after a consensus between Neurosurgery and Trauma.
· Prophylactic anticoagulation
will be used if not contraindicated.
3. All Other Extreme Risk Patients:
· Consider prophylactic IVC filter.
· In general, IVC filter will be
used unless strong relative contraindications exist, such as young age,
likelihood of future pregnancy, feasibility of anticoagulation and patient preference.
· Prophylactic anticoagulation
will be used if not contraindicated.
·
Continue pneumatic compression hose.
|
Risk Level |
Risk Factors* |
Screening |
Prophylaxis |
|
Low Risk (rare in
SICU) |
Not a Major Trauma Victim, no risk factors |
No routine screening required |
Mandatory ambulation in 1st 24-36 hours In-bed mobility and lower extremity exercises NO SCDs or anticoagulation |
|
High Risk |
Major Trauma Victims (presence of >1 of following): 1. likelihood of bedrest >3 days, head injury, spine or pelvic fracture, lower extremity fracture 2. laparotomy, thoracotomy or laparoscopy co-morbid risk factors* including: history of prior DVT or PE, obesity, known sepsis, malignancy, hypercoagulable state, pregnancy |
1st Duplex in 24 hours; 2nd in first week; then weekly by the Radiology duplex lab. If patient needs a study prior to placing Venodynes, call Radiology Department Duplex Lab. |
SCDs and LMWH (lovenox 30mg sc bid 1, 2 started within 24 hours of admission or fondaparinux 2.5mg qd started within 6-8 hours of admission |
|
Extreme Risk |
Major Trauma Victims (presence of >1 of following): 1. severe head injury with therapeutic paralysis and aggressive ICP control >5-7 days 2. spinal fracture with para- or quadriplegia 3. unstable pelvic fracture with bedrest >6 weeks 4. multiple lower extremity fractures 5. patient in High Risk group where usual measures cannot be employed |
Same as High Risk |
IVC filter: 1. Head injury w/ chemoparalysis for >5-7 days with LE or pelvic fracture should have IVC filter after 4th or 5th day (Neuro + Trauma discussion) 2. Isolated head injury requiring paralysis >5-7 days will be considered for prophylactic IVC filter or anticoagulation 3. SCI will receive IVC filter after consensus between Neurosurgery and Trauma. 4. All other high risk patients consider IVC filter |
1: If impaired renal function, consult pharmacy. 2:
adjust dose if BMI > 30, consider pharmacy consult. 3: in liver patients,
may start up 48-96 hours post-op, if no major risk of bleeding
38
1. Age older than 50 years
2. History of prior VTE
3. History of myocardial infarction
4. History of cancer
5. History of atrial fibrillation
6. History of ischemic stroke
7. History of diabetes mellitus
8. History of CHF
9. History of obesity
10. History of paralysis
11. History of varicose veins
12. History of inhibitor
deficiency state:
a.
Factor V Leiden
b.
prothrombin gene mutation
e.
antithrombin III deficiency
f.
anticardiolipin antibodies
a. No neurosurgical consultation will be required for patients with a GCS≥14
with a normal scan and the patient
has normal state of alertness. (Scan must be reviewed by Trauma Attending & Radiologist)
b. General indication for CT
head scan
i.
Any patient with a traumatic mechanism of injury with known or suspected (amnestic) loss of
consciousness should be considered for a CT
scan.
c. If GCS does not improve to
15 within 6-8 hours of injury or if
state of alertness is abnormal – obtain a neurosurgical consult.
d. If the clinical picture is predominated
by drugs, toxic substances, and/or alcohol, in addition to the CT scan, the
patient should be followed with neuro checks for 12 to 24 hours.
e. A neurosurgical consultation
will be obtained for:
i.
any unexplained neurological deficit
ii.
any deterioration in GCS or state of
alertness
iii.
GCS≤13 (head CT scan
will also be obtained)
iv.
abnormal head CT scan
v.
evidence of skull fracture including clinical signs suggesting skull
fracture, or CSF, raccoons eyes, Battle sign
vi.
spine fracture or spinal cord injury (only if on spine call)
vii.
evidence of peripheral nerve injury
viii.
other patients at discretion of the trauma attending/fellow
All simple lacerations are to be managed and repaired by the Trauma Service. For patients sustaining complex lacerations and/or fractures to the face, the Plastic Surgery Service is to be consulted on all odd days of the month and the Head & Neck Service is to be consulted on all even days of the month.
For patients being transferred from an outside facility, with or without an isolated upper extremity/hand injury, early consultation is mandatory to ensure timely availability of required staff and personnel.
General
Guidelines for Approach to Traumatic Orthopaedic Injuries
a. Open Fractures
i.
All open fractures irrespective of type require immediate irrigation and debridement (I&D).
The optimal time is within six hours from injury.
ii.
If the patient cannot be taken to the OR within six hours of injury due
to problems with clearance by trauma surgery
or neurosurgery, a preliminary I&D will be performed at the bedside
to decrease the amount of gross contamination. However, this is not an adequate procedure and the
patient will require operative debridement as soon as medical clearance is obtained.
iii.
Neurosurgery will be involved in the evaluation and management of many
poly-trauma patients. It is their responsibility to communicate with the Trauma
Service regarding the status of the patient's neurologic injury. Ultimately, it
is the decision of the Trauma Service regarding the timing of orthopaedic
surgery and overall management.
iv.
The orthopaedic resident on-call is responsible for contacting the
Orthopaedic Attending on-call
if a patient
with an open fracture
is delayed for greater than six
hours of if a bedside I&D is
v.
Operative stabilization of open fractures is almost always required to assist
with bony as well as soft tissue stabilization. This includes a variety of
procedures including external fixation and internal fixation with nails or plates. Temporary fixation can be
achieved with open fractures using an external fixator. This should not add a
significant amount of time to the procedure. If any concern exists, the
Orthopaedic Attending can give a reasonable estimate regarding the duration of
the procedure.
b. Pelvic Fractures
i.
Patients with significantly displaced or unstable pelvic fractures,
especially the "open book"
variety, are candidates for emergent external
fixation.
1.
The most common method of stabilizing these injuries is an external
fixator. This can be accomplished in the trauma bay if necessary but preferably
in the operating room.
2.
If needed, a flat sheet can be wrapped circumferentially around the
patient's pelvis until the patient is in the operating room. This should be accomplished quickly and should
only serve as a temporary measure until
definitive fixation can be achieved. Otherwise, the sheet can cause skin necrosis. Pelvic binders are now available in the trauma bay. If the resident is unable to find one, please ask a trauma tech.
ii.
If the fracture pattern is not amenable to external fixation i.e.:
significant posterior injury or iliac wing
fracture extension, angiography can be considered
if there is evidence of bleeding.
c. Skeletal Traction
i.
All femoral shaft fractures, acetabular fractures, and vertically
unstable pelvic fractures should
be placed in skeletal traction.
ii.
The goal is to minimize
the number of joints spanned
between the fracture and traction pin. Therefore, a
distal femoral traction pin is preferred for acetabular and pelvic fractures
and a proximal tibial pin for femoral shaft fractures.
iii.
X-rays should be obtained of the knee to rule-out fractures prior to
inserting either of these traction pins.
d. Compartment Syndrome
i.
When the diagnosis of compartment syndrome has been made, the patient must
be taken to the operating room immediately for
fasciotomies.
ii.
The first procedure includes releasing all compartments and no effort
is made to close the wound.
iii.
The patient will then return to the operating room 2 to 3 days later for
delayed closure +/- split thickness skin grafting.
a. Trauma patients who have
sustained multi-system injury often have many
services involved in their treatment. The Trauma Service provides the
coordination for decision making and priority setting for the multiple specialties.
b. The patient who has
sustained both orthopedic and neurologic injury requires a planned approach.
c. All patients with open fractures,
severe soft tissue injury, open joint lacerations, irreducible dislocations,
progressive neurologic or vascular deficits, compartment syndromes, and pelvic
fractures requiring fixation to assist in hemorrhagic shock management should
be taken to the Operating Room within 6
to 8 hours.
d. When it is not possible to
achieve this timeframe, the reason should be
documented.
e. Every effort should be made
to address the issue preventing that patient from going to the operating room.
f. When the head injury
evaluation determines that the patient is at risk for a secondary brain injury, anesthesia management must be
continuously supervised by an attending anesthesiologist experienced in trauma anesthesia.
g. When a decision regarding
operation is required, the merits and risks of ICP monitoring, the type and
techniques of anesthesia, and the routes of fixation will be explored to accomplish the best
combination of orthopedic stabilization while maintaining optimal overall
patient care.
h. If the operative plans
(procedure or approximate length of the surgery) change either preoperatively
or intraoperatively, the Ortho Service should notify the Trauma Service Chief, Fellow, or Attending.
|
Glasgow Coma Scale |
CT Results |
Non-urgent Orthopaedic Injuries |
Urgent Orthopaedic Injuries |
|
14-15 |
Normal |
Proceed with appropriate fixation |
Proceed with appropriate fixation |
|
11-13 |
Normal but persistent ABNORMAL level of consciousness |
Consider repeat CT scan in 12-24h versus Proceed with appropriate fixation after discussion of ICP placement for intra- operative monitoring. Requires discussion by the 3 surgery attendings & anesthesia |
ICP placement for intra- operative monitoring |
|
11-15 |
Abnormal, without evidence of increased ICP |
Proceed with appropriate fixation after discussion re: time and potential EBL. Requires discussion by the 3 surgery attendings and anesthesia. |
ICP placement for intra- operative monitoring. |
|
11-15 |
Abnormal, with evidence of increased ICP |
Wait 72 hours, then discuss operative procedure based on patient course. Requires discussion by the 3 surgery attendings & anesthesia. |
ICP monitoring; attempt rapid I&D, reduction or fasciotomy, possible rapid Ex Fix or pinning. Requires discussion by the 3 surgery attendings & anesthesia. |
|
3-10 |
|
Case by case determination by discussion with 3 surgery attendings & anesthesia. (Possible Neurosurgical resident to go to O.R.) |
ICP monitoring (Possible Neurosurgical resident to go to O.R.); minimum orthopedic procedures unless unable to tolerate or able to tolerate more intervention |
44
(see Appendix J Analgesia/Sedation Protocol for Mechanically Ventilated Patients)
Clinical Practice Guidelines for 1 the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit
Agitation may result from inadequately treated pain,
inadequate sedative therapy, ventilator dysynchrony, and/or ICU delirium.
·
The need for the ongoing
management of pain,
agitation, and delirium
should be reassessed often in ICU patients (1B).
·
ICU patients should be awake and able to purposefully follow commands,
unless a clinical indication for deeper sedation exists (1B).
·
Use a multidisciplinary team approach, including: 1) provider
education; 2) preprinted and/or computerized protocols and order forms;
and 3) a quality ICU rounds checklist, to implement and facilitate pain,
agitation, and delirium management guidelines and protocols in adult
ICUs (1B).
·
Pain assessment should be routinely performed in all ICU patients (1B).
·
Self-report is preferred
over the use of behavioral pain scales in patients who are able to communicate (B).
·
The BPS and CPOT* are the most valid and reliable behavioral pain
scales for use in ICU patients who cannot self-report (B).
·
Vital signs should
not be used alone to assess pain,
but they may be used adjunctively for pain
assessments (2C).
·
Preemptively treat chest
tube removal with either analgesic and/or non-pharmacologic therapy
(1C).
·
Suggest preemptively treating other types of procedural pain with
either analgesic and/or non-pharmacologic therapy (2C).
·
Use opioids as first-line therapy for treatment of non‐neuropathic pain (1C).
·
Use gabapentin or carbamazepine, in addition to opioids, for treatment of neuropathic pain (1A).
·
Use thoracic epidural
anesthesia/analgesia for postoperative analgesia in abdominal
aortic surgery patients (1B).
·
Suggest thoracic epidural analgesia for patients with traumatic rib
fractures (2B).
·
Depth and quality
of sedation should
be routinely performed
in all ICU patients (1B).
·
The RASS and SAS† are the most valid and
reliable scales for assessing quality and depth of sedation in ICU patients (B).
·
Target the lightest
possible level of sedation and/or
use daily sedative
interruption (1B).
·
Use sedation protocols and checklists
to facilitate ICU sedation management (1B).
·
Suggest using analgesia‐first sedation for intubated and mechanically ventilated ICU patients (2B).
·
Promote sleep in ICU patients
by controlling light and noise, clustering patient
care activities, and decreasing stimuli at night (1C).
·
Delirium assessment should be routinely performed in all ICU patients (1B).
·
The CAM‐ICU and ICDSC delirium
monitoring tools are the most valid and reliable in ICU patients
(A).
·
Mobilize early when feasible to reduce the incidence and duration of
delirium, and to improve functional outcomes
(1B).
·
Avoid antipsychotics in ICU patients who are at risk for torsades de pointes.
·
Avoid benzodiazepines in ICU patients
with delirium unrelated
to ETOH/benzodiazepine withdrawal (2B).
· Suggest using dexmedetomidine over benzodiazepines for sedation of ICU patients
with delirium (2B).
*: Behavioral Pain Scale (BPS) and the Critical-Care Pain Observation Tool
(CPOT).
†: Richmond Agitation-Sedation Scale (RASS) and
Sedation-Agitation Scale (SAS).
Protocol:
This protocol is intended to guide the ICU team in providing the most efficient and effective care plan that will result in the liberation from mechanical ventilation.
The protocol is referred to as STEER in consideration of these 5 key components:
Screen for contraindications
Test readiness by utilizing RSBI/Tobin Index
Exercise
Evaluate progress
Report information to clinicians
Procedure:
a. Within 24 hours of a patient
being mechanically ventilated, the Respiratory Care Practitioner (RCP) will ask
the physician to enroll the patient into the Ventilator STEER Protocol.
b. The Ventilator STEER
Protocol will be initiated on patients by a written order from the physician. This protocol may be ordered as:
i.
STEER Protocol
ii.
The Ventilator STEER Protocol
iii.
RT Protocol for Ventilators
iv.
RT Consult for Ventilators
c. After the physician has
written an order, a qualified RCP will:
i.
assess the patient upon receipt of the physician's order
ii.
transcribe the plan in the physician's order section of the medical
record, label the entry as "PDP" and include their signature and credential
iii.
transcribe an order, per protocol, for the appropriate ventilator
settings that are defined by each category
iv.
assess all mechanically ventilated adult patients twice on a daily basis
to determine if the rapid shallow breathing index (RSBI)/Tobin Index can be
measured
The RSBI/Tobin Index is calculated as f/Vt (liters).
v.
The RSBI/Tobin Index is not to be measured if any of the following criteria has been noted during the assessment:
1. PEEP >5 2. FiO2 >.45
3. SaO2 <92%
4. hemodynamic instability 5. HR >140
6. unstable angina
7. increased ICP
8. neuromuscular blockers
9. sedation drip
10. T° >39 and/ or
11. the physician has requested
patient not to have measurements or trials completed
If one or more of these factors have been identified, the patient is to be classified as a “do not complete RSBI/Tobin Index.” The RCP will then document it on the sprint/trial flow sheet and into the RCMIS.
vi.
Once a patient has no contraindications to perform the RSBI/Tobin
Index, and an order has been obtained for the Ventilator STEER Protocol to be
initiated, the RCP will perform the RSBI twice a day by placing the patient on
CPAP of 0-5 and PS of 1-5 for one minute.
vii.
Patients are placed on trials and their care plans are driven by the
RSBI/Tobin Index measurement.
d. Based on the RSBI/Tobin Index
i.
CPAP Trial with Pressure
Support of 1-5 x2 Hours
If the RSBI is <100, the RCP will place the patient on a CPAP Trial for 2 hours with the same FiO2, PEEP and have PS of 1-5 and/or flowby of 10/3 added.
After the trial has been completed, the RCP should repeat the RSBI/Tobin Index.
If the patient completes the CPAP trial successfully, the RCP will contact the MD to request for the patient to be extubated or for further plans. Once an order has been obtained for extubation, the patient should proceed to the Extubation Protocol.
If the patient did not complete the CPAP trial successfully, the trial should be stopped and repeated again in 4-6 hours. Patients who do not progress in the trials x 48 hours are classified as “Failure of CPAP Trial, not progressing.” The MD should then be informed.
If the RSBI is >100, the physician can select either Augmented Pressure Support trials or SIMV/PS trials. If however, no preference has been made, the trial of choice at UCSD Medical Center is the Augmented Pressure Support mode. Please note that once a mode has been selected, it should be utilized throughout the duration of the trials for RSBIs >100.
i.
Augmented Pressure Support
Trial x30 minutes
If the RSBI is >100, the RCP will place the patient on an Augmented Pressure Support trial for 30 minutes with the same FiO2 and PEEP. If no Pressure Support trial has been completed, the patient should be placed on a PS of 20 and then decreased by 5 until their respiratory rate is between 25-35 breaths/minute.
If the patient completes the Augmented Pressure Support successfully, the RSBI should be repeated again in 4-6 hours. If the RSBI/Tobin Index remains
<100, the pressure support used during the next trial should be decreased by 5.
If the patient did not complete the Augmented Pressure Support successfully the trial should be stopped and the RSBI should be repeated again in 4-6 hours. If the RSBI/Tobin Index remains >100, the settings used for the last successful trial will be used during the next trial. Patients who do not progress in the trials x 48 hours are classified as “Failure of Augmented Pressure Support Trial, not progressing.” The MD should then be informed.
ii.
SIMV/PS Trial x30 minutes
If the RSBI >100, the RCP will place the patient on a SIMV/PS trial for 30 minutes with the same Vt, FiO2, and PEEP. To establish the rate for SIMV, the “assisted rate” must be determined by placing the patient on A/C of 2 for five minutes. If the patient exceeds 35 breaths per minute, the trial will be terminated and repeated in 4-6 hours. If the RR is <35, the patient will be placed on SIMV mode and the starting SIMV rate is the “assisted rate” minus four. Pressure Support of 1 to 5 is then added.
The patient will continue on the trial for thirty minutes. If the patient completes the SIMV/PS trial successfully, the RSBI should be repeated in 4-6 hours.
For the next trial, if the RSBI remains >100, the patient will remain on the same parameters if the RR had increased >30% and was <35 over the course of the last trial. If the RR did not increase by 30% during the previous trial, the SIMV rate will be decreased by 2. Once the patient is on a rate <4, the patient will be CPAP of 5.
If the patient did not complete the trial successfully, the trial will be stopped and reassessed for the RSBI again in 4-6 hours. If the trial failed due to a RR
>35, the settings used for the next trial should be from the last successful trial. Before the trial is terminated, the SIMV rate can be increased by two (up to two times), if the rate is still >35.
The RCP will add additional PS (in increments of 5) up to a PS of 20, until the RR is <35. The patient will continue on the trial for thirty minutes. If the patient completes the trial successfully, the patient will be reassessed in 4 to 6 hours. If the RSBI remains >100, the patient will remain on the same parameters if the RR had increased >30% and was <35 over the course of their last trial. If the RR did not increase by 30% during the previous trial, the PS will be decreased by 5. Once the patient is on a PS of 1-5, the SIMV rate will be decreased.
If the patient did not complete the trial successfully, the trial will be stopped and repeated again in 4-6 hours. If the trial failed due to a RR >35, the settings used for the next trial should be from the last successful trial. Before the trial is terminated, the PS rate can be increased by 5 (up to two times), if the rate is still >35.
Patients who do not progress in trials x48 hours are classified as “Failure of SIMV/PS trail, Not Progressing.”
e. If at any time the patient
has transitioned from a “do not
complete RSBI/Tobin Index,” the RCP will notify the MD before the
initiation of the first trial. The only exception to this is if the patient has
under gone post-op surgery within the past 24 hours.
f. Termination of STEER Trials
A trial will be terminated if a patient experiences one or more of the following:
i.
B/P is <90 or >170
ii.
RR is >35 for a duration of five
minutes
iii.
there is a change in HR of 20% or >130/beats per minute
iv.
the temperature is >39
v.
there is a 50% reduction in the minute
ventilation
vi.
arrhythmias are noted
vii.
SaO2 <90 or within physician
specified limits.
If the patient experiences arrhythmias during the trial, the MD/RN should be notified and the trial should not be repeated until approval has been given by the physician to proceed.
If the RCP notes contraindications, observes an adverse response, the responsible physician and R.N. will be immediately informed.
g. Failure to progress in trials x48 hours
Patients who do not progress in trials x48 hours are classified as “failure of trial, not progressing”. The MD should then be informed.
Patients in this category may require more extensive evaluations due to their inability for readiness to being taken off mechanical ventilation. They will, however continue to undergo assessments and if the RSBI can be obtained, be initiated on trials, unless the patient is taken out of the protocol by an order from their physician.
h. Open Heart Patients
All open-heart patients that are ordered on the Ventilator STEER Protocol will begin their first trial at 05:00 A.M. If patients are too sedated to begin at 5:00 A.M., the RCP will attempt their first assessment every hour (up to three times.
i. Pulmonary Considerations
The RCP should know the signs of increasing ventilatory insufficiency and patient distress, and discontinue or hold the trials if the patient has:
i.
increasing tachypnea associated with patient distress
ii.
agitation, panic, diaphoresis, or tachycardia, unrelieved by
reassurance and adjustment of the mechanical ventilation system
iii.
respiratory acidemia defined as an acute drop in pH to <7.25 to
7.30, associated with an increasing PaCO2
iv.
Successful extubation requires the ability to protect the upper airway
and clear secretions adequately in addition to successful discontinuation of
ventilatory support. These factors should be considered and addressed prior and
subsequent to extubation.
v.
The RCP should confirm the emergency availability of either the
Attending, Fellow or Anesthesiologist and apprise them of plans to extubate the
patient. A specific M.D. order is then required for extubation.
vi.
Problems which may occur during trials:
1. cardiovascular collapse
2. arrhythmias
3. poor muscle strength
4. increased work of breathing
5. excessive secretions
6. primary illness not resolved
7. pulmonary complications
(e.g., atelectasis, pulmonary infection, bronchospasm)
8. continued use of sedatives
or analgesics
9. acid-base imbalance
10. electrolyte imbalance
11. abdominal distention
12. anemia
13. fluid overload
14. renal failure
15. malfunction of equipment
j. Boundaries/Interactions
i.
After an order has been written, the RCP may initiate and discontinue trials per RT Protocol.
ii.
Physicians and nursing will be informed of the patient’s progress
by the RCP through direct
communication and appropriate documentation on the sprint/trial flow sheets.
iii.
The RCP and RN should coordinate activities that will optimize the schedule for the trials.
iv.
Modalities outside the limits of the protocol require a
physician’s order.
v.
The RCP will also notify the M.D. and R.N. of any acute changes in the patient's condition.
k. Guidelines and Warnings
i.
The responsible physician and R.N. should be contacted if the:
1. RCP is unable to determine
appropriate care upon evaluation.
2. RCP observes an unfavorable
assessment of the patient which would
mandate that the trials be stopped and the patient reassessed. (see f.Termination of STEER Trials)
3. patient fails to progress as
expected x 48 hours
l. Rx Plan
Upon completion of the assessment and after contacting the physician and R.N. for any indicated modification in the care plan, the RCP will initiate the Ventilator STEER Protocol per the algorithm and protocol guidelines.
m. Documentation
The RCP will document the RSBI/Tobin Index and related monitored parameters on the sprint/trial flow sheet and in the RCMIS. The ICU Coordinator will maintain a record of the “non-chart sprint/trial worksheets” for a 90-day period.
n. Outcome Evaluated
Outcome is determined by clinical and physiologic assessment to establish adequacy of patient response to the trials.
Clinical goals for trials:
i.
to minimize complications of mechanical ventilation
ii.
PaO2 >65mm Hg on room air
iii.
SaO2 >90% or within physician's
specified limits
iv.
resolution of underlying disease process
v.
RR< 35
o. Assessment
All patients in the Ventilator STEER Protocol will be assessed twice on a daily basis to determine if a RSBI/Tobin Index can be performed and determine what type of trials can be initiated. Ongoing assessment will accompany trials to assure the efficiency of readiness for the removal of mechanical ventilation.
p. Justification of Discontinuation of Mechanical Ventilation
Patients will be discontinued from the Ventilator STEER Protocol if their response requires interventions outside of the protocol or when the patient has been successfully taken off mechanical ventilation.
The following guidelines have been developed to assist physicians with the appropriate selection of prophylactic and empiric antibiotic therapy for potential and common infections seen in SICU patients at UCSD. These guidelines were developed with knowledge of “nosocomial” pathogens seen in this unit.
Treatment should be directed by patient-specific parameters which include: gram stain, culture and sensitivity information (when they are known), previous infectious diseases and antibiotic courses, and other pertinent medical history, including drug allergies. Duration of antibiotic treatment should be based on specific organism(s), site of infection, and clinical scenario.
The drug(s) of choice listed below are the most active, least toxic and most cost- effective agents currently on the UCSD Formulary. Dosing guidelines are for patients with “normal” renal and liver function. Many antibiotic dosages must be adjusted with altered renal function.
Infectious Disease consultation should be obtained for patients with unusual isolates, complicated infectious disease management problems, and those who are responding poorly to empiric therapy.
MRSA Screening: California State Law requires all admissions to an ICU undergo MRSA screening via a nasal swab. This must be ordered by a physician. The only exemption is those patients already known to be MRSA positive.
ICU Antibiotics Rules of Thumb:
1.
How sick is the patient?
Patients with signs and symptoms of sepsis or who are immunocompromised need early, broad spectrum therapy. Delay can be fatal. Prolonged ventilation and prior antibiotic use (especially of broad-spectrum agents) predispose to resistance.
2.
Know the organism
Ideally you should be treating a known organism with an appropriate dose of antibiotic to which that organism is likely to respond, based on sensitivity testing. This ideal will often not be met. Sometimes you will obtain an organism and its sensitivity on routine microbiological surveillance and then the patient will show features of infection likely to be due to that organism. More often, you will have to rely on empiric therapy.
3.
Know the environment
Know the patterns of resistance, and the organisms prevalent the ICU environment. This helps with antibiotic choice. The current UCSD Antibiograms are available on the Infection Control pages via links on the intranet homepage.
4.
Identify the site of infection
Positive blood cultures are simply not good enough. Identify the site of infection (i.e. respiratory tract, urinary tract, a subdiaphragmatic collection, etc.) and address any surgically remediable pathology right away. The primary treatment of an abscess, for example, is steel – i.e. immediate drainage, not antibiotics.
5.
Don't overtreat
Never treat a "fever" or a "leukocytosis" with antibiotics. Assess the patient as a whole, including their predisposition to infection, and likely sites of infection. Ask whether the patient is sick enough to justify antibiotics, rather than treating laboratory values! If you are going to start 'empiric' therapy, first obtain microbiological specimens for culture. Document your reasons for starting therapy, and choose as narrow an antibiotic spectrum as you can reasonably 'get away with'. When you get the results of ID + sensitivity testing, revise your treatment to 'narrow- down' the spectrum as far as possible.
6.
Don't delay
If the patient clearly needs treatment, treat. Do NOT wait for sensitivity results - if the patient is ill and needs treatment now, sensitivity results will make a very poor epitaph. The primary lesson of River’s Early-goal-directed therapy in sepsis trial is to be EARLY!
7.
Don't undertreat
Even more important than giving adequate doses of an antimicrobial is not to give an agent that has a substantial likelihood of failure. In a critically ill patient, you may not
get a second chance. The wrong antibiotic can increase mortality risk by more than 3 times!
8.
Know how critical illness
interacts with the antibiotic
The pharmacokinetics of antimicrobials are often substantially altered in the critically ill, especially with renal failure.
9.
In vitro response is not the
same as in vivo
There are some agents that appear to be effective in vitro, but will not work in vivo. Always look at sensitivity results in the light of your knowledge of the microbe and the patient (and especially the site of infection!).
10. Don't treat for too long
We usually give antibiotics for too long. For infections like VAP, if the patient has responded dramatically, is clinically much improved, and leukocytosis and fever have subsided for 24 to 48 hours, cessation of antibiotic therapy is a good idea. There are notable exceptions to this guideline - infective endocarditis and deep- seated Staphylococcus aureus infections, for example, must be treated for prolonged periods.
11. Get Help
The SICU has a team of surgical intensivists, clinical pharmacists and infectious disease consultants who can provide excellent advice.
a. Post-Coronary Artery Bypass
Graft and /or Heart Valve Replacement
·
Routine prophylaxis: cefuroxime 1.5 g IV q12h x48h
·
MRSA colonized patients: cefuroxime 1.5 g IV q12h and vancomycin 1g IV q12h x48h
·
ALLERGY to Penicillin: vancomycin 1 g IV q12h and aztreonam 2g IV q12h
x48h
·
Adjust doses for altered renal function
b. Ventriculostomy or ICP
Monitor Placement
·
No prophylactic antibiotic therapy required
c.
Posttraumatic Open Fracture
·
Gustilo Grade I: cefazolin 1-2g IV q8h x24h
·
Gustilo Grade II & III: cefazolin 1-2gm IV q8h and gentamicin x24-72h
CrCl (mL/min) Dose Interval
≥60 5 mg/kg q24h
30-59 5 mg/kg q48h
·
Dose is based on actual, or if patient is obese, then adjusted body weight,
·
Patients in an ICU should receive 6 mg/kg
·
Alternative therapy if patient is allergic to Penicillins or Cephalosporins:
o
Vancomycin (patient-specific dose), usual 15 mg/kg IV q12h
o
Plus or minus gentamicin (dosing as
above)
d. Penetrating Abdominal Trauma
and/or Surgical Procedure
·
piperacillin-tazobactam (Zosyn®) 3.375 g IV q 8h - one dose pre-op
·
Continue x 24 hrs post-surgical procedure or definitive therapy only if hollow
viscous injury
e. Routine Chest Tube Insertion
·
No prophylactic antibiotic therapy required
f.
Ventilator Associated Pneumonia (VAP)
Patient has been ventilated more than 48 hours AND a new and persistent infiltrate on CXR PLUS TWO of the following:
1. febrile ≥ 38.3ºC,
2. elevated WBC, or
3. increased, purulent sputum
(ask nurse about suctioning)
If yes, this is a suspect VAP case (PNU1):
1. Order Bronchoscopy +
quantitative bronchoalveolar lavage (BAL), C&S.
2. Start antibiotics after BAL:
piperacillin-tazobactam (Zosyn®) 3.375 g IV q8h
and vancomycin 1g IV q12h (pharmacy will adjust dose)
3.
If positive C&S (PNU2), narrow antibiotics for sensitivities and
continue 5- 7 days
4. If negative C&S and WBC
and fever resolve, discontinue antibiotics
g. Presumed Aspiration
Witnessed or presumed aspiration after traumatic event (i.e. loss of consciousness, vomitus in oropharynx, vomitus seen on intubation, or suspect infiltrate on initial CXR): clindamycin 600 mg IV q8h and ciprofloxacin 400 mg IV q12h x48h unless symptoms and signs of pneumonia
a. Fungal Overgrowth on Mucous Membranes
Often seen after administration of broad-spectrum antibiotics and does not necessarily require treatment. If desired, nystatin 5-10cc oral swish & swallow/spit qid
b. Candidal Cystitis
Change Foley to Silicone Foley. Except in neutropenic patients, Candida in the bladder rarely disseminates and does not infect the kidneys.
If for some reason you wish to eradicate Candida in patients with Foley catheters: amphotericin B 20mg in 200cc sterile water; infuse into bladder q d for 3-5 days
c. Abdominal Sepsis
Many nosocomial Candida species are resistant to fluconazole, which should not be used for routine prophylaxis. Significant fungal infection in abdominal sepsis following surgery is rare and usually only seen in “tertiary peritonitis” – persistent abdominal sepsis after surgery and antibiotics, usually accompanied by multiple organ failure and/or in immunocompromised states. In such patients, optimal drainage should be ensured and cultures obtained. Obtain ID consult. Options include micafungin 100 mg IV q24h. An alternative is voriconazole 6 mg/kg IV q12h first day, followed by 3 mg/kg q12h.
d. Disseminated Fungal
Infection or Systemic Disease Suspected Suspect systemic disease with:
1. Positive blood cultures
(<50% sensitive).
2. Multiple deep site isolation
in a patient with fevers and not doing clinically well
3. Isolation from urine plus
wound or multiple sites.
Obtain Infectious disease consult, options include micafungin 100 mg IV q24h. An alternative is voriconazole at 6 mg/kg IV q12h first day, followed by 3 mg/kg q12 h.
Note: An isolated positive
sputum for C. albicans is not an indication for antifungal
therapy.
a. In the absence of
contraindications to enteral feeding, provision of nutrition should be initiated within the first 24
hours of admission
b. Post-pyloric feeding tubes are
the “preferred” route and location for providing nutrition.
c. Placement of post-pyloric
feeding tubes may be achieved via:
i.
Cortrak
ii.
Interventional radiology
iii.
Endoscopy
Based on clinical studies, the indications for stress ulcer prophylaxis will be graded according to the following scale:
|
Grade |
|
|
A |
Convincing evidence, indicated |
|
B |
Some evidence, probably indicated |
|
C |
No evidence, indication uncertain |
|
D |
Not recommended, not indicated |
The following criteria have an “A” rating
a. ICU patients:
i.
intubated for respiratory failure
ii.
with coagulopathy
iii.
on corticosteroids
b. Surgical ICU patients with:
i.
single or multiple organ failure
ii.
major infectious complications
iii.
acute trauma spinal cord injury with neurologic deficit
iv.
multiple trauma (ISS > 25)
v.
neonates NPO plus multiple doses of
dexamethasone
vi.
major burn injury >35% TBSA The following criterria have a “B” rating
c. ICU patients:
i.
on anticoagulation
ii.
with multiple organ failure
iii.
with intracranial hypertension
d. Inpatients:
i.
with prolonged NPO status
(> 5 days) with GI pathology or after major
surgery
ii.
with acute renal failure
iii.
with hepatic failure
iv.
on anticoagulation with
1. comorbid disease
2. age >60
3. history of UGIB
4. on NSAIDs
v.
liver transplant patients NPO on immunosuppression
vi.
patients on any dosage of corticosteroids with predisposing conditions
for PUD or on NSAIDs or on high doses of corticosteroids (>1 G prednisone)
The following criteria have a “C” rating:
e. Inpatients:
i.
NPO
ii.
with coagulopathy (elevated PT/PTT)
iii.
on anticoagulation
iv.
neonates NPO plus multiple organ failure, liver or renal failure or
coagulopathy
The following criteria have a “D” rating
f. These conditions are not independent
indications for stress ulcer prophylaxis:
i.
advanced malignancy
ii.
bacteremia without sepsis
iii.
advanced age (>60)
iv.
chronic NSAID usage
v.
total corticosteroids dosage (< 1 g
prednisone)
g. Judicious use of stress
ulcer prophylaxis may be responsible for a decreased incidence of stress
ulceration; adverse drug reaction; drug interactions; and unnecessary expense.
h. In most patients that meet
criteria for stress ulcer prophylaxis, full oral or intra-gastric enteral
nutrition serves as adequate protection. However, some patients remain at high risk
for ulcer-related bleeding despite routine enteral feeding. These include, but are not limited to
patients in a. i-iii. In these high
risk patients, enteral feeding may not provide adequate prophylaxis and
additional pharmacological agents are indicated.
i. Intra-gastric feeds with
high residuals may indicate GI pathology, therefore, neither oral pharmacothherapy or enteral feeds should be
considered adequate protection.
j. In a patient who tolerates
liquids for greater than 24 hours, the intravenous
medication may be switched to oral therapy.
k. There is no data supporting
the use of concomitant sucralfate and an H2-antagonist.
l. Stress Ulcer Prophylaxis Drugs of Choice
Studies have shown equal prophylactic efficacy between H2-antagonists, antacids and sucralfate.
There is also data available that intra-gastric feeds serve as adequate stress ulcer prophylaxis.
|
Agent |
Cost per Day ($) |
|
Famotidine 20 mg IV q 12h |
8.00 |
|
Famotidine 40 mg/day continuous IV infusion |
3.50 |
|
Famotidine 20 mg po q 12h |
2.20 |
|
Sucralfate 1 g PO q6h |
2.08 |
|
Nitrolan 80ml/hr |
6.57 |
For patients with cuffed endotracheal (oral/nasal) tube or cuffed tracheostomy tube, enteral feeds should be continued until time of surgery whether gastric or post-pyloric placement of feeding tube
For patients who DO NOT have a cuffed endotracheal or tracheostomy tube, feeds need be stopped eight (8) hours prior to anticipated surgery.
1. Patient is unresponsive;
makes no spontaneous movements and does not
respond to ANY stimuli (this does not include spinal reflex)
2. Absent cranial reflexes
·
Fixed pupils
·
No corneal reflexes
·
No oculocephalic reflex (eyes remain
immobile)
·
No response to iced/cold calorics
·
No cough or gag reflex
3. No spontaneous respiratory
efforts with apnea test
4. No residual effect of hypothermia
temperature or CNS depressants.
Temperature must be > 32 degrees C or 90 degrees F.
5. If EEG done, it should be isoelectric
6. If cerebral blood flow study
done, there should be no blood flow to the
brain
Documentation
Two physicians must document brain death in the progress notes with the date and time. They must not be a part of the transplant team
California
Brain Death Law
A person shall be pronounced dead if a physician determines that the person has suffered a total and irreversible cessation of the entire brain. There will be independent confirmation of death by another physician.
The legal time of death is the 2nd declaration.
Apnea Test
It is recommended that the apnea test be performed as follows:
1. Prerequisites:
·
Core Temperature 36.5°C or 97°F
·
Systolic blood pressure 90
mm Hg
·
Corrected diabetes insipidus (Positive
fluid balance)
·
Normal PCO2 (Arterial PCO2 of 35-45 mm Hg)
2. Pre-oxygenate with 100% O2 for 30 minutes, draw baseline ABG.
3. Connect a pulse oximeter and
disconnect the ventilator
4. Place a nasal cannula at the
level of the carina and deliver 100% O2, 8 L per minute
5. Look closely for respiratory
movements (abdominal or chest excursions that
produce adequate tidal volumes)
6. Measure PO2, PCO2, and pH after 10 minutes
and reconnect the ventilator
7.
If respiratory movements are absent and arterial PCO2 is 60 mm Hg (option: 20 mm Hg increase in PCO2 over a baseline normal PCO2), the apnea test result is
positive (supports the diagnosis of brain death)
8.
If PCO2 is 60 mm Hg or PCO2 increase is > 20 mm Hg over baseline normal PCO2, the apnea test is positive [supports the clinical
diagnosis of brain death]
9. If the PCO2 is < 60 mm Hg or PCO2 increase is < 20 mm Hg
over baseline normal PCO2, the result is
indeterminate and an additional confirmatory test can be considered.
a. The Department of Surgery
conducts a weekly Morbidity and Mortality Conference,
Wednesday at 0630.
b. Standard Department of
Surgery Resident Report for Weekly M&M includes:
i.
number of admissions
ii.
number of OR resuscitations
iii.
number and types of operations and
procedures
iv.
number and type of complications
v.
number of deaths
vi.
summary of resident work hours
It is imperative that residents discuss and review weekly M&M with the trauma attending at least 1 day prior to Departmental Rounds to ensure accuracy and completeness of data.
c. An M&M must be sent in
per department policy. Please check in with your chief resident on how to
submit an M&M.
d. Each Trauma M&M is also
reviewed in a monthly “Select Case Review” as an internal process
of the Division of Trauma.
e. All patients in-house with complications, as well as discharged patients, will have M&M forms filled out during the reporting period
preceding each Wednesday’s M&M meeting.
f. The operating resident will be responsible for the details of a concise
presentation and reconstruction of the case and will be responsible for
obtaining all imaging studies (x-rays, CT scans, etc.) If the operating resident
cannot be physically present at M&M when the case is presented, he/she will
designate someone to present the case and will inform the chief resident about the substitution. The chief resident will
be ultimately responsible for the presentation, imaging studies, etc.
g. All cases will be presented
on the Wednesday of the week following their
discharge. The time and date of the case presentation will not be determined
by the resident or attending based upon their schedules. Please let the
attending of the case know when their patient is being presented. If you would
like the attending to review the case prior to Wednesday, please email the
Powerpoint presentation in a timely fashion.
These guidelines are to be used to assist in clinical efficiency but
are not a substitute for clinical
judgment.
i.
coordinate care and anticipate future
needs
ii.
assist with determination of treatment
plan
iii.
anticipate needs to discharge
iv.
aid in transition to home or care facility
v.
ensure patient/family and nursing staff education regarding:
1.
treatments/therapies administered
2.
possible complications
3.
wound care
4.
activity
5.
follow-up visits
A. Key Outcomes
·
Timely diagnosis of injury
·
All potential injuries ruled out or diagnosed within 24 hrs
·
Prompt intervention for identified injuries
·
Alcohol Screening and Brief Intervention (SBI), as appropriate
Exceptions: associated injuries requiring additional treatment
i.
Prior to Arrival at Admission Destination
·
ATLS protocol; workup as mechanism and presentation dictate
ii.
At the Time of Admission
·
Timely diagnosis and clear treatment plan of injuries
·
Admit to ward (ICU/IMU/Floor) as appropriate
Hospital Day
#1
·
Rule out major traumatic injury
·
Complete initial survey and full physical exam documented
·
H&P completed and signed by resident/Attending
·
Consultation(s) as appropriate
·
Administration of appropriate therapies (i.e. wound care, pulmonary
toilet, spinal precautions/neurologic/neurovascular checks as indicated)
·
Serial abdominal exam documented
·
Obtain final staff radiology x-ray readings/clearance for injury
·
Additional labs and radiographic imaging as required
Hospital Day
#2
·
Perform tertiary survey to rule out possibility of missed injuries
·
C-spine clearance as per Protocol
·
Follow up on and clarify consultants’ plans for treatment
·
D/C Foley (if placed)
·
Initiate/continue with regular diet
·
Discuss discharge planning
·
Patient and family education regarding wound care, diet, and activity
Tolerating regular diet
Activity as tolerated based on injuries Clinic follow-up as injuries dictate
Per PT/OT recommendations
A. Key Outcomes
•
Timely diagnosis and intervention of facial fractures and associated injuries
•
Early establishment of need for operative intervention
•
Optimal pain management; aggressive pulmonary toilet; early mobilization
24-48 hours (depends on associated injuries, type of fracture/complexity of surgery, if required)
i.
Prior to Arrival at Admission Destination
·
ATLS protocol; workup as mechanism and presentation dictate
·
HNS or Plastics evaluation
·
Antibiotics and tetanus prophylaxis as
needed
ii.
At the Time of Admission
·
Timely diagnosis and clear treatment plan of injuries
·
Admit to ward (ICU/IMU/Floor) as appropriate
·
NPO for surgery as dictated by scheduling
iii.
Postoperative
If jaw wired shut:
1.
Wire cutters at bedside
2.
Oral rinses
3.
Jaw fracture diet
4.
Dietary consult
Hospital Day
#1
·
Immediate repair of facial fractures or consider outpatient management
·
Follow up on and clarify consultants’ plans for treatment
Hospital Day
#2
·
Perform tertiary survey to rule out possibility of missed injuries
·
C-spine clearance as per Protocol
·
Patient and family education regarding wound care, diet, and activity
·
Timely diagnosis of facial fractures, TBI, and associated injuries
·
Prompt intervention for facial fractures, TBI, and identified injuries
·
Early recognition of neurological deterioration and immediate
institution of appropriate workup and therapies
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
Depends on associated injuries, type of fracture/complexity of surgery
i.
Prior to Arrival at Admission Destination
·
ATLS protocol; workup as mechanism and presentation dictate
·
HNS or Plastics and Neurosurgery evaluation
·
Antibiotics and tetanus prophylaxis as
needed
ii.
At the Time of Admission
·
Admit to ICU/IMU as appropriate
·
Scheduled neurologic checks
iii.
Postoperative
If jaw wired shut:
1.
Wire cutters at bedside
2.
Oral rinses
3.
Jaw fracture diet
4.
Dietary consult
Hospital Day
#1
·
Repeat CT head
·
24 hours of serial neurologic exams
Hospital Day #2
·
Perform tertiary survey to rule out possibility of missed injuries
·
C-spine clearance as per Protocol
·
Repair of facial fractures or consider outpatient management
·
Timely diagnosis of esophageal injury and associated injuries
·
Prompt intervention for esophageal injury and identified injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
24-48 hours (depends on severity of injury/complexity of surgery)
i.
Prior to Arrival at Admission Destination
·
ATLS protocol; workup as mechanism and presentation dictate
·
Operative exploration of Zone II injury
·
Antibiotics and tetanus prophylaxis as
needed
Hospital Day
#1
·
Start clear liquid diet
Hospital Day
#2
·
Remove drain
·
Discharge
·
Patient and family education regarding wound care, diet, and activity
Tolerating regular diet
Activity as tolerated based on injuries Clinic follow-up as injuries dictate
Home in uncomplicated cases Home care facility in complex cases Per PT/OT recommendations
·
Timely diagnosis of esophageal injury and associated injuries
·
Prompt intervention for esophageal injury and identified injuries.
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
5 days (depends on severity of injury/complexity of surgery/presence or absence of leak on postop contrast study)
i.
Prior to Arrival at Admission Destination
·
ATLS protocol; workup as mechanism and presentation dictate
·
Operative exploration of Zone II injury
·
Antibiotics and tetanus prophylaxis as
needed
Hospital Day #1-#4
·
NPO
·
Antibiotics
·
Drainage
Hospital Day
#5
·
Contrast study
o If negative, start clear liquid diet AND continue drainage
Hospital Day #6
·
If no evidence of esophageal leak with clear liquid diet, remove drain
·
Discharge
·
Patient and family education regarding wound care, diet, and activity
Tolerating regular diet
Activity as tolerated based on injuries Clinic follow-up as injuries dictate
Home in uncomplicated cases Home care facility in complex cases Per PT/OT recommendations
·
Timely diagnosis and treatment of hemo/pneumothorax and associated injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
·
Respiratory parameters maintained within acceptable limits
·
Full expansion of lung and adequate evacuation of hemothorax
·
Patient demonstrates and verbalizes understanding of wound/dressing
care at discharge
2-4 days (persistent air leak or ongoing chest tube output may lengthen stay)
Hospital Day #1
·
Consider IMU/ICU admission for elderly patients or if other
complicating factors exist
·
NPO
·
Chest tube to -20 cm H20 suction
·
Closely monitor chest tube output and assess for air leak
·
Adequate analgesia, consider
need for epidural
·
Aggressive pulmonary toilet; weaning parameters BID by RT
·
OOB to chair while CT on suction
Hospital Days
#2-3
·
AM chest x-ray
o
if persistent hemo/pneumothorax OR continuous air leak, continue chest
tube to suction and monitor
o
if hemo/pneumothorax resolved AND no continuous air leak, place chest
tube to straight drainage and repeat chest x-ray in 4-6 hrs
o
if chest x-ray stable after 4-6 hrs on water seal and output
<150cc/24hr, remove tube
·
Advance diet
·
Adequate analgesia (IV or po)
·
Aggressive pulmonary toilet; weaning parameters BID by RT
·
OOB to chair while CT on suction; may ambulate while on water seal
Hospital Day
#4
·
AM chest x-ray
o
if persistent hemo/pneumothorax OR continuous air leak, continue chest
tube to suction and monitor
o
if hemo/pneumothorax resolved AND no continuous air leak, place chest
tube to straight drainage and repeat chest x-ray in 4-6 hrs
o
if chest x-ray stable after 4-6 hrs on water seal and output
<150cc/24hr, remove tube
·
Change analgesia to oral route
·
Ambulate TID once chest tube is off suction; may ambulate while on
water seal
·
Keep site dressing in place x 48hr
Tolerating regular diet
Activity as tolerated based on injuries Clinic follow-up as injuries dictate
* Patients admitted with a pneumothorax should be instructed to abstain from air travel for a minimum of 4 weeks following clinical and radiographic resolution of a pneumothorax.
Care facility required for complex cases
May require home care for assistance with wounds or other therapies Per PT/OT recommendations
·
Timely diagnosis of liver injury and associated injuries
·
Prompt recognition of failure of nonoperative management
·
Prompt intervention for failure of nonoperative management and identified injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
Exceptions: Unsatisfactory resolution of organ injury OR associated injuries requiring additional treatment
i.
Prior to Admission to ICU or IMU
1.
ATLS protocol; work-up as mechanism and presentation dictate
2.
patient must be hemodynamically stable
3.
abdominal ultrasound/CT scan abdo/pelvis
4.
Labs: ABG, H & H, type and screen
D. Discharge Planning
Regular diet
Clinic follow-up q1-2 weeks x4 weeks; every month thereafter or at discretion of Trauma Attending
Restricted activity for 8-12 weeks total or at discretion of Trauma Attending May require home care follow-up
Dependent on needs at discharge (home vs. SNF vs. rehabilitation) Per PT/OT recommendations
|
|
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
|
Location |
SICU |
SICU |
IMU |
IMU/Floor |
Floor |
|
Diet |
NPO |
NPO |
Sips/CF |
CF/DAT |
DAT |
|
Activity |
Bedrest
Pulmonary toilet |
Bedrest
Pulmonary toilet |
Up to Chair Pulmonary
toilet |
AAT Pulmonary toilet |
AAT |
|
Vitals |
Q4-6H |
Q6H |
Q6-8H |
Routine |
Routine |
|
IV fluids |
Yes |
Yes |
Yes |
No |
No |
|
Labs |
Q6H |
Q6-12H |
BID-QD |
QD |
QD |
|
DVT |
SCDs Duplex protocol |
SCDs Duplex protocol |
LMWH Duplex protocol |
LMWH Duplex protocol |
|
|
Disposition |
|
|
Discharge |
Discharge |
Discharge |
A. Key Outcomes
·
Timely diagnosis of liver injury and associated injuries
·
Prompt intervention for identified injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
Exceptions: Associated injuries requiring additional treatment and/or postoperative complications
C. Proposed Hospital Course (see table below)
i.
Preoperative
1.
ATLS protocol
2.
work-up as mechanism and presentation
dictate
3.
CT head as indicated
4.
Rule out pelvic fracture if indicated
5.
FAST/ diagnostic peritoneal lavage/CT scan abdo/pelvis
6.
Labs: ABG, H & H, type and cross
ii.
Postoperative
1.
admit to SICU
2.
daily postoperative CBC/coagulations, chemistries/LFTs as indicated
3.
arterial line +/- Swan-Ganz catheter
4.
NGT
5.
aggressive pulmonary toilet
6.
pain management
D. Discharge Planning
Regular diet
Activity as tolerated based on associated injuries. Follow-up in clinic
May require home health follow-up
Dependent on needs at discharge (home vs. SNF vs. rehabilitation) Per PT/OT recommendations
|
|
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
|
Location |
SICU |
SICU |
IMU |
IMU/Floor |
Floor |
|
Diet |
NPO |
NPO |
Sips/CF |
CF/DAT |
DAT |
|
Activity |
Bedrest
Pulmonary toilet |
Bedrest
Pulmonary toilet |
Up to Chair Pulmonary
toilet |
AAT Pulmonary toilet |
AAT |
|
Vitals |
Q4-6H |
Q6H |
Q6-8H |
Routine |
Routine |
|
IV fluids |
Yes |
Yes |
Yes |
No |
No |
|
Labs |
Q6H |
Q6-12H |
BID-QD |
QD |
QD |
|
DVT |
SCDs Duplex protocol |
SCDs Duplex protocol |
LMWH Duplex protocol |
LMWH Duplex protocol |
|
|
Disposition |
|
|
|
|
Discharge |
A. Key Outcomes
·
Timely diagnosis of splenic injury and associated injuries
·
Prompt recognition of failure of nonoperative management
·
Prompt intervention for failure of nonoperative management and identified injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
Exceptions: Unsatisfactory resolution of organ injury, associated injuries requiring additional treatment
i.
Prior to Admission to ICU or IMU
1.
ATLS protocol
2.
work-up as mechanism and presentation
dictate
3.
patient must be hemodynamically stable
4.
FAST/ CT scan abdo/pelvis
5.
Labs: ABG, H & H, type and screen
D. Discharge Planning
Regular diet
Clinic follow-up q1-2 weeks x4 weeks; every month thereafter or at discretion of Trauma Attending
Restricted activity for 8-12 weeks total or at discretion of Trauma Attending May require home care follow-up
Dependent on needs at discharge (home vs. SNF vs. rehabilitation). Per PT/OT recommendations
|
|
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
|
Location |
SICU |
SICU/IMU |
IMU |
IMU/Floor |
Floor |
|
Diet |
NPO |
NPO |
Sips/CF |
CF/DAT |
DAT |
|
Activity |
Bedrest
Pulmonary toilet |
Bedrest
Pulmonary toilet |
Up to Chair Pulmonary
toilet |
AAT Pulmonary toilet |
AAT |
|
Vitals |
Q4-6H |
Q6H |
Q6-8H |
Routine |
Routine |
|
IV fluids |
Yes |
Yes |
Yes |
No |
No |
|
Labs |
Q6H |
Q6-12H |
BID-QD |
QD |
QD |
|
DVT |
SCDs Duplex protocol |
SCDs Duplex protocol |
LMWH Duplex protocol |
LMWH Duplex protocol |
|
|
Disposition |
|
|
Discharge |
Discharge |
Discharge |
A. Key Outcomes
·
Timely diagnosis of splenic injury and associated injuries
·
Prompt intervention for identified injuries
·
Optimal pain management; aggressive pulmonary toilet; early mobilization
·
Administration of appropriate vaccinations prior to discharge from hospital
Exceptions: Associated injuries requiring additional treatment and/or postoperative complications
i.
Preoperative
1.
ATLS protocol
2.
work-up as mechanism and presentation
dictate
3.
CT head as indicated
4.
Rule out pelvic fracture if indicated
5.
FAST/ diagnostic peritoneal lavage/CT scan abdo/pelvis
6.
Labs: ABG, H & H, type and cross.
ii.
Postoperative
1.
admit to SICU
2. daily postoperative
CBC/coagulations, chemistries/LFTs as indicated
3. arterial line +/- Swan-Ganz catheter
4. NGT
5. aggressive pulmonary toilet
6. pain management
D. Discharge Planning
Regular diet
Activity as tolerated based on associated injuries Follow-up in clinic
May require home health follow-up
Dependent on needs at discharge (hove vs. SNF vs. rehabilitation). Per PT/OT recommendations
|
|
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
|
Location |
SICU |
SICU |
IMU |
IMU/Floor |
Floor |
|
Diet |
NPO |
NPO |
Sips/CF |
CF/DAT |
DAT |
|
Activity |
Bedrest
Pulmonary toilet |
Bedrest
Pulmonary toilet |
Up to Chair Pulmonary
toilet |
AAT Pulmonary toilet |
AAT |
|
Vitals |
Q4-6H |
Q6H |
Q6-8H |
Routine |
Routine |
|
IV fluids |
Yes |
Yes |
Yes |
No |
No |
|
Labs |
Q6H |
Q6-12H |
BID-QD |
QD |
QD |
|
DVT |
SCDs Duplex protocol |
SCDs Duplex protocol |
LMWH Duplex protocol |
LMWH Duplex protocol |
|
|
Disposition |
|
|
|
|
Discharge |

The paramedic is given 45 seconds before the patient is moved to give an MIVT report. The only time the paramedic will not be allowed to give the MIVT report is when patients have a need for CPR, or are in need of immediate airway control. In those instances, the team will proceed with moving the patient over and continuing with CPR and intubating the patient and then subsequently get reports from the paramedics. As a reminder, here are the elements of the MIVT report:
M = Mechanism of injury
Include all mechanisms of injury, including a description of all blunt mechanisms as well as penetrating injuries.
I = Injuries identified or injuries suspected
Paramedics usually describe, in addition to obviously identified injuries, areas where the patient has complained of pain or soreness.
V = Vital signs including level of consciousness
If the patient’s vital signs have been stable the paramedic does not need to specify lost blood pressure or pulse. He can simply state vital signs have been stable throughout. It is very important for the paramedic to state level of consciousness and if possible, Glasgow Coma Scale. If the level of consciousness has waxed and waned, or decreased in any way, it is important to make note of this. It is also at this point that the paramedic should note unequal or fixed and dilated pupils, if he is aware of them.
T = Treatment or therapies and response to therapies
If the patient had low blood pressure and received a fluid challenge of crystalloid to which his blood pressure responded, it should be noted here. If the patient had lack of a distal pulse prior to traction splint application which returned or did not return after application of the splint, it should be noted here.
|
Team Member |
Pre-admission |
Primary Assessment |
Secondary Assessment |
|
DOCTOR 1 (Head of
Bed) |
Puts on lead apron/universal precautions Assigns roles Checks intubation equipment Gives pre-admission plan |
Identifies self to paramedics Initial evaluation Manages airway Immobilizes neck/C-spine Directs team members Decides type and # of IVs Prioritizes x-rays Prioritizes procedures Orders type & amount of blood Orders lab work |
Orders consults Does head to toe/back exam Reads x-rays Decides disposition Talks with family |
|
DOCTOR 2 (side opposite
Monitoring Nurse) |
Puts on lead apron |
Assists with airway Undresses patient Establishes additional IV access Manual control of bleeding from head/neck/torso Performs diagnostic procedures Inserts monitoring lines Applies warm blankets |
Assists with thorough clinical exam Assists with drawing blood |
|
DOCTOR 3 (Left leg) |
Puts on lead apron |
Undresses patient Assesses need for Foley Does rectal exam unless contraindicated |
Examines lower extremities Immobilizes fractures Draws arterial blood from groin Does hem-occult test |
|
Team Member |
Pre-admission |
Primary Assessment |
Secondary Assessment |
|
MONITORING NURSE |
Writes MIVT info on Blackboard Puts out Trauma Page Puts on lead apron Flushed IV’s Readies videotape Pulls pre-stamped AKA packet |
Assesses radial pulse Assists with airway Takes blood pressure Gives vital signs Q 2-3 minutes Assesses IV patency Numbers IV bags Applies ID arm band |
Gives meds and IVs Updates hemodynamic monitoring information (Fluids, ABG, MEDS) Accompanies & monitors patients on transports |
|
CIRCULATING NURSE |
Puts on lead apron Flushes & calibrates A-line Turns suction on high (connects Yankauer) Gets warm blankets |
Ensures bloods are processed Readies Pleurevacs PRN Uses autotransfusion Directs attainment of supplies Assists with procedures Obtains 2nd IV if needed |
Places EKG leads Ensures equipment for transport Interfaces with other departments Takes temperature |
|
TRAUMA TECH |
Readies (ice, tubes, syringes) for blood drawing Receives pre-stamped AKA packet Readies videotape Places patient info in Log Book |
Assists with obtaining equipment Collects valuables and clothes Assists with obtaining blood from groin |
Processes valuables and clothes Receives blood tubes to prepare labs Takes lab work to Blood Bank and Labs as “Trauma STAT” Answers telephones Pages consults Places patient info in log book |
1. Hold specimen to blood bank
2. ABG or VBG with hematocrit/hemoglobin
3. Urine Tox immunoassay
4. Blood Alcohol level (BAL)
All regular labs above, plus:
1.
PT/PTT/INR
2.
CBC
3.
If on Plavix, order Plavix assay
All regular labs above, plus:
1.
PT/PTT/INR
2.
CBC
3.
Chem 10
All regular labs above, plus:
1.
PT/PTT and fibrinogen
2.
CBC
3.
Kleihauer-Betke
4.
Type and Screen
All regular labs above, plus:
1.
ABG with H/H and carboxyhemoglobin
2.
CBC
3.
PT/PTT/INR
4.
Chem 10 with LFT’s and albumin
5.
If electrical injury:
a. Cardiac markers
b. CPK
H.
Tertiary Survey of Trauma Patient
Date and Time: / / Pain score:
Physical examination should include BOTH inspection for injuries (i.e. lacerations, abrasions, contusion, swelling, ecchymosis) AND palpation for injuries (i.e. tenderness, deformity, subcutaneous emphysema, guarding).
Glasgow Coma Scale (GCS) =
1.
Head & Neck
Scalp □ □
Face □ □
Eyes □ □
Ears □ □
Mouth □ □
Neck □ □
C-spine
a. midline tenderness yes □ no □
b. C-spine cleared □ radiographically AND □ clinically
2. Chest □ □
3. Abdomen/Pelvis □ □
4. Back □ □
5. Extremities/MSK □ □
|
Motor R L R L Deltoid: Iliopsoas: Biceps: Quads: Triceps: Hams: Wrist Ext.: TA: Wrist Flex.: EHL: Finger Flex.: G/S: Interossei: |
Vascular R L Brachial: Radial: Femoral: Popliteal: Dors. pedis: Post. Tibialis: |
|
Sensory |
Reflexes Rectal tone: Bulbocavernous relex: Abdominal reflex: Cremasteric reflex |
Performed Final Performed Final
3 view C-spine: yes □ no □ □ CT head: yes □ no □ □
CXR: yes
□ no □ □ CT head: yes □ no □ □ PXR: yes
□ no □ □ CTA neck: yes □ no □ □ TLS: yes
□ no □ □ CT chest: yes □ no □ □ Extremities: yes
□ no □ □ CT A/P:
yes □ no □ □ FAST: yes
□ no □ □ Angiogram: yes □
no □ □
Other:
yes □ no □ □
C.
Diagnosis List (Underline new diagnosis NOT identified after 1° or 2° surveys)
|
1. |
6. |
|
2. |
7. |
|
3. |
8. |
|
4. |
9. |
|
5. |
10. |
![]()
Evaluating Provider: MD/NP/PA Faculty Signature: 3° Survey Complete: □ C-spine
Cleared: □
|
UCSDMC DIVISION OF TRAUMA
RAPID SEQUENCE
INTUBATION (RSI) ADULT - TRAUMA
![]()
Surgical Consultation
20 mL/kg Ringer’s Lactate Solution as Bolus (May Repeat One or Two Times)
![]()
![]()
Hemodynamics Hemodynamics Normal Abnormal
![]()
Further Evaluation 10
mL/kg PRBCs
![]()
Transfer as Necessary Normal Abnormal
![]()
Observe Operation Further Operation Evaluation
![]()
![]()
Transfer as Necessary
Observe Operation
Approach to the Child with Multiple
Injuries
1. Open airway with modified jaw thrust while maintaining manual in-line cervical spine stabilization.
2. Clear oropharynx with rigid suction device and pediatric Magill forceps as indicated.
3. Administer 100% oxygen via nonrebreathing mask if child is awake and breathes spontaneously.
4. Hyperventilate with 100% oxygen using bag-valve mask if child has altered mental status or respiratory distress.
5. Perform Sellick maneuver followed by orotracheal intubation if child is unresponsive or has signs of respiratory failure.
6. Maintain airway patency using appropriate suction device and oropharyngeal airway as
necessary.
7. Initiate CPR and control external bleeding as indicated.
8. Examine chest for tension/open pneumothorax; treat if found.
9. Establish venous access; obtain type and crossmatch.
10. Rapidly infuse 20mL/kg isotonic crystalloid solution if signs of inadequate systemic perfusion are present.
11. Immobilize neck with semirigid collar or head immobilizer and tape.
12. Insert nasal or orogastric tube and decompress stomach.
13. Infuse second crystalloid bolus and give blood as necessary if signs of shock or major hemorrhage are present.
14. Ensure that pediatric trauma surgeon has been notified.
|
|
Class I |
Class II |
Class III |
Class IV |
|
Blood Loss |
Very mild hemorrhage (<15% blood volume loss) |
Mild Hemorrhage (15%-25% blood volume loss) |
Moderate Hemorrhage (26%-39% blood volume loss) |
Severe Hemorrhage (>40% blood volume loss) |
|
Cardiovascular |
Heart rate
normal or mildly increased Normal pulses |
Tachycardia Peripheral
Pulses may be diminished |
Significant tachycardia
Thready peripheral pulses |
Severe tachycardia Thready
central pulses |
|
Respiratory |
Rate normal |
Tachypnea |
Moderate
tachypnea |
Severe
tachypnea |
|
Central Nervous System |
Slightly
anxious |
Irritable,
confused |
Irritable or
lethargic |
Lethargic |
|
Skin |
Warm, pink Capillary
refill brisk |
Cool extremities, mottling
Delayed capillary refill |
Cool extremities,
mottling, or pallor Prolonged capillary refill |
Cold extremities, pallor,
or cyanosis |
|
Kidneys |
Normal urine
output |
Oliguria, increased
specific gravity |
Oliguria,
increased BUN |
Anuria |
Modified from American College of Surgeons. Advanced Trauma Life Support Course. 4th ed. Chicago, Ill; American College of Surgeons; 1992, and Fleisher GR, Ludwig S. Textbook of Pediatric Emergency Medicine. 2nd ed. Baltimore, Md: Williams & Wilkins; 1998.
Reproduced with permission from Soud T, Pieper P, Hazinski MF.
Pediatric Trauma. In: Hazinski, MF, ed. Nursing
Care of the Critically Ill Child.
2nd ed. ST. Louis, Mo: Mosby Year Book; 1992.
|
Drugs
Used in Pediatric Advanced Life Support |
||
|
Drug |
Dosage
(Pediatric) |
Remarks |
|
Adenosine |
0.1-0.2
mg/kg Maximum single dose: 12 mg |
Rapid IV bolus |
|
Atropine
sulfate* |
0.02 mg/kg |
Minimum dose: 0.1 mg Maximum
single dose: 0.5 mg in child, 1.0 mg in adolescent |
|
Bretylium |
5 mg/kg; may be increased to 10 mg/kg |
Rapid IV |
|
Calcium chloride
10% |
20 mg/kg |
Give slowly. |
|
Dobutamine hydrochloride |
2-20 mg/kg per min. |
Titrate to desired effect |
|
Dopamine
hydrochloride |
2-20 mg/kg per min. |
a-Adrenergic action dominates at > 15-20
mg/kg
per min. |
|
Epinephrine
for bradycardia* |
IV/IO: 0.01 mg/kg (1:10,000, 0.1 mL/kg) ET: 0.1 mg/kg (1:1000, 0.1 mL/kg) |
|
|
Epinephrine for asystolic or pulseless arrest* |
First dose: IV/IO: 0.01 mg/kg (1:10,000, 0.1 mL/kg) ET: 0.1 mg/kg (1:1000, 0.1 mL/kg) IV/IO doses as high as 0.2
mg/kg of 1:1000 may be effective. Subsequent
doses: IV/IO/ET: 0.1 mg/kg (1:1000, 0.1 mL/kg) ·
Repeat every 3-5 min. IV/IO doses as high as 0.2 mg/kg of 1:1000 may
be effective. |
|
|
Epinephrine
infusion |
Initial at
0.1 mg/kg per min Higher infusion dose used if asystole present |
Titrate
to desired effect (0.1-1.0 mg/kg per min) |
|
Lidocaine* |
1 mg/kg |
|
|
Lidocaine
infusion |
20-50 mg/kg per min |
|
|
Naloxone* |
If < 5 years old or < 20 kg: 0.1 mg/kg If
> 5 years old or > 20 kg: 2.0 mg |
Titrate to desired effect. |
|
Prostaglandin
E1 |
0.05-0.1 mg/kg per min |
Monitor for apnea, hypotension, hypoglycemia |
|
Sodium
bicarbonate |
1 mEq/kg per dose or 0.3 x kg x base deficit |
Infuse slowly and only if ventilation is adequate |
|
* For ET administration dilute medication with
normal saline to a volume of 3 to 5 mL and follow with several
positive-pressure ventilations. |
||
![]()
|
Appendix J1 UCSD
Medical Center Disaster Plan Trauma
Resuscitation Room (TRR) Rationale: To provide primary receiving area for
patients in need of emergency surgery evaluation and operative treatment. Primary Location: Second
Floor adjacent to SICU Secondary Location: Shock
and Holding (PACU) or as announced by the Incident Command
Center Contact Phone Number: 543-7428 FAX Number: 543-5716 Responsible Departments: Department of Surgery, Division of Trauma; Department of Anesthesiology Primary
Responsibilities: 1.
Resuscitate severely injured patients. 2.
Perform basic diagnostic studies (lab, x-ray) on trauma patients. 3.
Triage patients in order of severity of injury. 4.
Make appropriate dispositions (OR, ICU, Floor). 5.
Expedite transfer of patients out of TRR once workup is complete to
allow new patients to be admitted. 6.
Report all patient movements and transfers to the ICC. Team
Membership: 1.
On call trauma attending physician or fellow. 2.
Additional trauma staff as available. 3.
Chief, senior, and junior residents on Trauma Service. 4.
Junior residents on other general surgery services, Neurosurgery, and Cardiothoracic surgery services. 5.
Resuscitation Room nurses from SICU. |
Appendix J2 UCSD Medical Center Shock and Holding Area Rationale: To provide secondary receiving area for patients
in need of emergency surgery evaluation and operative treatment. Primary Location: Second
Floor Recovery Room (PACU) Secondary Location: To be
announced by the Incident Command Center Contact Phone
Number: 543-6130 FAX Number: None Responsible Department: Department of Surgery, Division of Trauma Department of Anesthesiology Primary
Responsibilities: 1.
Resuscitate severely injured patients. 2.
Perform basic diagnostic studies (lab x-ray) on trauma patients. 3.
Triage patients in order of surgical priority, for operating room time. 4.
Make appropriate dispositions (OR, OR preop holding, ICU, Floor). 5.
Hold and stabilize patients requiring surgery for whom Operating Room
are not yet available. A
pre-operative area will be set aside for the purpose. If needed, patients can be transferred
to the ICU/Floor while awaiting surgery. 6.
Report all patient movement and transfers to the ICC. Team
Membership: 1.
On call trauma attending physician or fellow. 2.
Additional trauma staff as available. 3.
Attendings, residents, and interns on General Surgery Services. 4.
Cardiothoracic fellow, surgery attendings, and interns. 5.
Neurosurgery attendings, chief resident and interns. 6.
All attendings and residents from Plastic Surgery, ENT, and Urology Services. 7.
Anesthesia staff and residents. 8.
PACU nurses. 9.
Trauma Coordinator. |
96
Chemical, Biological Weapons:
Diagnosis: Be alert to the following –
·
Groups of
individuals becoming ill around the same time
·
Sudden increase of illness in previously healthy individuals
·
Sudden increase in the following non-specific illnesses:
· Pneumonia, flu-like illness, or fever with atypical features
· Bleeding disorders
· Unexplained rashes, and mucosal or dermal irritation, blisters, sloughing
· Neuromuscular illness, unexplained weakness in previously healthy individuals
· Simultaneous disease outbreaks in human and animal populations
· Unusual temporal or geographic clustering of illness (for example, patients who attended the same public event, live in tthe same part of town, etc.).
Confirmation and technical support
·
Alert laboratory, consult infectious disease specialist
·
Alert Trauma Director, hospital leadership, to
consider Code Orange, Disaster Plan
·
Call San Diego County Division of Community Epidemiology:
Mon-Fri - (619) 515-6620, Weekends, after hours - (858) 565-5255
· Epidemiology will call FBI: (858) 499-7904 or (858) 565-1255 & CDC :(800) 311-3435
·
For help in clinical diagnosis call CDC hotline (770-488-7100)
Decontamination considerations
·
Decontamination is best done before patient
enters hospital, treating patients in ER or Trauma bay before decontamination
may contaminate hospital
·
Clothing removal & biosafety bagging is
recommended, patient is washed off in shower outside ER
Standard Precautions (Mask, gown and gloves) should be worn for all
trauma victims
·
Follow infection control practices in Table 1
·
Handle equipment used according to standard
infection control practices
Treatment
considerations
·
See Tables 1 and 2
·
The terrorist
may be one of the initial/index cases!
Radiologic Weapons:
Diagnosis: Be alert to the following –
Acute radiation syndrome follows predictable pattern (Table 3), symptoms of concern:
·
2-3 week prior history of nausea and vomiting
·
thermal burn-like skin effects without thermal exposure
·
immune dysfunction with secondary infections
·
tendency to bleed (epistaxis, gingival bleeding, petechiae)
·
marrow suppression (neutropenia, lymphopenia, thrombocytopenia)
·
epilation (hair
loss)
Radiation exposure may be known and recognized or clandestine through
·
large recognized exposures, such as a nuclear
bomb or damage to a nuclear power station
· small
radiation source emitting continuous gamma radiation producing group or individual
chronic intermittent exposures (such as radiological sources from medical
treatment devices or environmental
water or food pollution)
Radiation exposure may result from any one or combination of the following
· external
sources (such as radiation from an uncontrolled nuclear reaction or
radioisotope outside the body)
·
skin contamination with radioactive material
(“external contamination”) OR internal radiation from absorbed,
inhaled, or ingested radioactive material (“internal contamination”)
Confirmation and technical support
·
Contact radiation safety officer (RSO) for help,
consult nuclear medicine physician
· Medical
Radiological Advisory Team (MRAT) at Armed Forces Radiobiology Research
Institute (AFRRI) 301-295-0530 will offer advice.
· Alert
Trauma Director, hospital leadership, to consider Code Orange, Disaster Plan
· Obtain CBC:
· absolute lymphocyte count <1000 mm3 suggests moderate exposure
· absolute lymphocyte count <500 mm3 suggests severe exposure
· Acute, short-term rise in neutrophil count suggests exposure
·
Swab mucosa (all body orifices – each
nostril, both ears, mouth, rectum) for counts
·
Collect 24-hour stool if GI contamination considered
·
Collect 24-hour urine if contamination is considered
Decontamination considerations
·
Exposure without contamination requires no
decontamination (RSO measurement)
· Exposure
with contamination requires Standard Precautions, removal of patient clothing, and decontamination with water
·
For internal contamination, contact the RSO
and/or Nuclear Medicine Physician
·
Patient with life-threatening condition: treat,
then decontaminate
·
Patient with non-life-threatening condition:
decontaminate, then treat
Treatment
considerations
·
If radioiodine (reactor accident) is present, consider
giving prophylactic potassium iodide (Lugol’s Solution) within first 24
hours only (ineffective later)
![]()
|
Disease |
Incubation |
Symptoms |
Signs |
Diagnostic
tests |
Transmission and Precautions |
Treatment (Adult dosage) |
Prophylaxis |
|
Inhaled Anthrax |
2-6 days Range: 2 day to 8 weeks |
Flu-like symptoms
Respiratory distress |
Widened mediastinum
on chest X-ray (from adenopathy) Atypical pneumonia Flu-like
illness followed by abrupt onset of respiratory
failure |
Gram stain
(“boxcar” shape) Gram positive bacilli in
blood culture ELISA for toxin antibodies to help confirm |
Aerosol
inhalation No person-to- person
transmission Standard precautions |
Mechanical ventilation Antibiotic therapy Ciprofloxacin 400 mg iv q
8- 12 hr Doxycycline 200 mg iv
initial, then
100 mg iv q 8-12 hr Penicillin 2 mil units iv q 2 hr -- possibly add gentamicin |
Ciprofloxacin
500 mg or Doxycycline 100 mg po Q 12 h ~ 8 weeks (shorter
with anthrax vaccine) Amoxicillin in pregnancy
and children Vaccine if available |
|
Botulism |
12-72 hours
Range: 2 hrs – 8 days |
Difficulty swallowing or speaking (symmetrical cranial
neuropathies) Symmetric descending
weakness Respiratory
dysfunction No sensory dysfunction No fever |
Dilated
or un-reactive pupils Drooping eyelids (ptosis) Double vision (diplopia)
Slurred speech (dysarthria) Descending flaccid paralysis Intact mental state |
Mouse bioassay in public health laboratories (5
– 7 days to conduct) ELISA for toxin |
Aerosol
inhalation Food ingestion No person-to-
person transmission Standard precautions |
Mechanical
ventilation Parenteral nutrition Trivalent botulinum antitoxin
available from State Health Departments and CDC |
Experimental vaccine has
been used in laboratory workers |
|
Plague |
1-3 days by inhalation |
Sudden onset of fever,
chills, headache, myalgia Pneumonic: cough, chest pain, hemoptysis Bubonic: painful
lymph nodes |
Pneumonic: Hemoptysis; radiographic pneumonia -- patchy, cavities, confluent
consolidation Bubonic: typically painful, enlarged lymph nodes in groin, axilla, and neck |
Gram
negative coccobacilli and bacilli in sputum, blood, CSF, or bubo aspirates (bipolar, closed
“safety pin” shape on Wright, Wayson’s stains) ELISA, DFA,
PCR |
Person-to-person
transmission in pneumonic forms Droplet precautions until patient treated for at
least three days |
Streptomycin
30 mg/kg/day in two divided doses x 10 days Gentamicin 1-1.75 mg/kg iv/im q 8 hr Tetracycline
2-4 g per day |
Asymptomatic contacts or
potentially exposed Doxycycline 100 mg po q 12 h Ciprofloxacin 500 mg po q 12
h Tetracycline 250 mg po q 6 hr all x 7 days Vaccine production
discontinued |
|
Tularemia “pneumonic” |
2-5 days Range: 1-21 days |
Fever, cough, chest
tightness, pleuritic pain Hemoptysis rare |
Community-acquired,
atypical pneumonia Radiographic:
bilateral patchy pneumonia with hilar adenopathy (pleural effusions like TB) Diffuse,
varied skin rash May be rapidly fatal |
Gram
negative bacilli in blood culture on BYCE (Legionella) cysteine- or S-H-
enhanced media Serologic testing to confirm: ELISA, microhemagglutinatio n DFA
for sputum or local discharge |
Inhalation of agents No person-to- person
transmission but laboratory personnel at risk Standard precautions |
Streptomycin 30 mg/kg/day
im divided bid for 10-14 days Gentamicin 3-5 mg/kg/day
iv in equal divided shoulders x 10-14 days Ciprofloxacin
possibly effective 400
mg iv q 12 hr (change to po after clinical improvement) x 10-14 days |
Ciprofloxacin
500 mg po q 12 hr Doxycycline 100 mg po q 12 hr Tetracycline 250 mg po q 6 hr
All x 2 wks Experimental live vaccine |
|
Smallpox |
12-14 days Range:7-17 days |
High
fever and myalgia; itching; abdominal pain; delirium Rash on face, extremities,
hands, feet; confused with chickenpox which has less uniform rash |
Maculopapular
then vesicular rash -- first on
extremities (face, arms, palms, soles, oral mucosa) Rash
is synchronous on various segments of the body |
Electron
microscopy of pustule content PCR Public health lab for
confirmation |
Person-to-person transmission Airborne precautions
Negative pressure Clothing and surface decontamination |
Supportive care Vaccinate
care givers |
Vaccination (vaccine
available from CDC) |
![]()
|
Agents |
Symptom Onset |
Symptoms |
Signs |
Clinical
Diagnostic Tests |
Decon- tamination |
Exposure
route and treatment
(adult dosages) |
Differential diagnostic considerations |
|
Nerve agents |
Vapor: seconds Liquid:
minutes to hours |
Moderate exposure: Diffuse muscle cramping,
runny nose, difficulty breathing, eye pain, dimming of vision, sweating, High exposure: The above plus sudden loss
of consciousness, flaccid paralysis, seizures |
Pinpoint pupils (miosis) Hyper-salivation Diarrhea
Seizures |
Red
Blood Cell or serum cholinesterase (whole blood) Treat for signs and
symptoms; lab tests only for later confirmation Collect urine for later
confirmation and dose estimation |
Rapid disrobing Water wash with soap and
shampoo |
Inhalation & dermal
absorption Atropine
(2mg) iv or im (titrate to effect up to 6 to 15 mg) 2-PAMCI 600mg injection or 1.0 g infusion over 20-30 minutes Additional
doses of atropine and 2- PAMCI depending on severity, Diazepam or lorazepam
to prevent seizures if >4 mg atropine given Ventilation support |
Pesticide
poisoning from organophosphorous agents and carbamates cause virtually
identical syndromes |
|
Cyanide |
Seconds to minutes |
Moderate
exposure: Dizziness, nausea, headache, eye irritation High
exposure: Loss of consciousness |
Moderate exposure: non-specific findings High exposure: convulsions, cessation
of respiration |
Cyanide (blood) or thiocyanate (blood or urine)
levels in lab. Treat for signs and
symptoms; lab tests only for later confirmation |
Clothing removal |
Inhalation & dermal absorption Oxygen
(face mask) Amyl nitrite Sodium
nitrite (300mg iv) and sodium thiosulfate (12.5g iv) |
Similar CNS illness results from: Carbon monoxide (from gas or diesel
engine exhaust fumes in closed spaces) H2S (sewer, waste,
industrial sources) |
|
Blister Agents |
2-48 hours |
Burning,
itching, or red skin Mucosal irritation (prominent tearing, and burning and
redness of eyes) Shortness
of breath Nausea and vomiting |
Skin erythema
Blistering Upper airway sloughing Pulmonary edema Diffuse
metabolic failure |
Often smell of garlic, horseradish, and mustard on body Oily droplets on skin from
ambient sources No specific diagnostic
tests |
Clothing
removal Large amounts of water |
Inhalation & dermal absorption Thermal burn type treatment Supportive care For
Lewisite and Lewisite/Mustard mixtures: British Anti-Lewisite (BAL or
Dimercaprol) |
Diffuse skin exposure with irritants, such as caustics, sodium
hydroxides, ammonia, etc., may cause similar syndromes. Sodium hydroxide (NaOH)
from trucking accidents |
|
Pulmo- nary agents (phosgene, etc) |
1 – 24 (rarely up to 72 hours ) |
Shortness of breath Chest
tightness Wheezing Mucosal and dermal
irritation and redness |
Pulmonary edema with some
mucosal irritation (more water
solubility = more mucosal irritation) |
No tests available but source assessment may help identify exposure
characteristics (majority of trucking incidents generating exposures to
humans have labels on vehicle) |
None usually needed |
Inhalation Supportive care Specific
treatment depends on agents |
Inhalation
exposures are the single most common form of industrial agent exposure (eg: HCl, Cl2, NH3 ) Mucosal irritation, airways
reactions, and deep lung effects
depend on the specific agent, especially water- solubility |
|
Ricin (castor bean toxin) |
18 – 24 hours |
Ingestion: Nausea, diarrhea, vomiting,
fever, abdominal pain Inhalation:,
chest tightness, coughing, weakness, nausea, fever |
Clusters of
acute lung or GI injury; circulatory collapse and shock |
ELISA (from commercial laboratories) using respiratory
secretions, serum, and direct tissue |
Clothing removal Water rinse |
Inhalation & Ingestion Supportive care For ingestion: charcoal
lavage |
Tularemia, plague, and Q fever may cause similar syndromes, as may CW
agents such as Staphylococcal enterotoxin B and phosgene |
|
T-2 myco- toxins |
2-4 hours |
Dermal
& mucosal irritation, blistering, and necrosis Blurred vision, eye
irritation Nausea, vomiting, and
diarrhea Ataxia Coughing and
dyspnea |
Mucosal erythema and hemorrhage Red skin,
blistering Tearing, salivation Pulmonary edema Seizures and coma |
ELISA
from commercial laboratories Gas chromatography/Mass spectroscopy in specialized laboratories |
Clothing removal Water rinse |
Inhalation & dermal contact Supportive care For ingestion: charcoal
lavage Possibly high dose steroids |
Pulmonary toxins (O3, NOx,
phosgene, NH3)
may cause similar syndromes though with less mucosal irritation. |
Table 3 Acute Radiation Syndrome
|
|
Whole body radiation
from external radiation or internal absorption |
||||||
|
Phase of Syndrome |
Feature |
Subclinical range |
Sublethal range |
Lethal range |
|||
|
0 – 100 rad (cGy) |
100 – 200 rad (cGy) |
200-600 rad (cGy) |
600-800 rad
(cGy) |
600-3000 rad
(cGy) |
>3000 rad (cGy) |
||
|
Initial or
prodromal |
Nausea, vomiting |
none |
5-50% |
50 –
100% |
75-100% |
90-100% |
100% |
|
Time of onset |
|
3-6 hrs |
2-4hrs |
1-2 hrs |
<1 hr |
<1 hr |
|
|
Duration |
|
<24 hrs |
<24 hrs |
<48 hrs |
<48 hrs |
<48 hrs |
|
|
Lymphocyte count |
|
|
< 1000 at
24 h |
< 500 at
24h |
|
|
|
|
CNS function |
No impairment |
No impairment |
Routine
task performance Cognitive impairment for 6-20 hrs |
Simple and routine task
performance Cognitive impairment for >24 hrs |
Progressive incapacitation |
||
|
Latent |
Duration |
> 2 wks |
7-15
days |
0-7 days |
0-2 days |
none |
|
|
“Manifest illness” (obvious illness) |
Signs and symptoms |
none |
Moderate leukopenia |
Severe
leukopenia, purpura, hemorrhage Pneumonia Hair loss after 300 rad
(cGy) |
Diarrhea
Fever Electrolyte disturbance |
Convulsions, ataxia,
tremor, lethargy |
|
|
Time of onset |
|
> 2 wks |
2 days – 2 wks |
2-3 days |
|||
|
Critical
period |
|
none |
4-6 wks |
5-14 days |
1-48 hrs |
||
|
Organ system |
none |
|
Hematopoietic and respiratory (mucosal) systems |
GI tract Mucosal systems |
CNS |
||
|
Hospitalization |
% Duration |
0 |
<5% 45-60 days |
90% 60-90 days |
100% 90+ days |
100% 2 weeks |
100% 2 days |
|
Fatality |
|
0% |
0% |
0-80% |
90-100% |
90-100% |
|
|
Time to death |
|
|
|
3
wks – 3 months |
1-2 wks |
1-2 days |
|
![]()
|
Headache Fatigue Weakness |
1o, 2o, 3o burns Epilation Ulceration |
|
Anorexia Nausea Vomiting Diarrhea |
Lymphopenia Neutropenia Thrombocytopenia Purpura Opportunistic infections |
ALERT AND
AWAKE PATIENT
C-SPINE IMMOBILIZATION
ASYMPTOMATIC PAIN
or TTP
Lateral C Spine in Trauma Bay
NEUROLOGIC DEFICITS
Need
additional CT imaging?
NO YES
NO
Follow Asymptomatic pathway
YES
➢ CT C Spine
➢
MANDATORY "SPINE TEAM" EVALUATION
X ray C spine images
CT C spine
Persistant pain?
Fracture?
Fracture?
NO YES
YES NO
NO YES
➢
Soft Collar for comfort Consider
MRI
T-L SPINE FILMS
➢ CT SCAN/MRI
➢ Hard Collar ➢
Consider
MRI/Spine team Evaluation
NORMAL
CLEAR
C-SPINE ➢ C-SPINE PRECAUTIONS ➢ “SPINE TEAM” EVALUATION ➢ T-L SPINE FILMS ➢ CT SCAN/MRI
ABNORMAL
![]()
102
➢ MAINTAIN C-SPINE PRECAUTIONS ➢ EXAMINE WHEN FULLY AWAKE ➢
FOLLOW
"AWAKE / ALERT PATIENT" ALGORITHM
YES
![]()
IF SIGNS OF OBSTRUCTION PRESENT: SUCTION
ORAL CAVITY TONGUE-JAW LIFT/ JAW THRUST ORO / NASOPHARYNGEAL AIRWAY ORO /
NASOTRACHEAL INTUBATION
BLUNT NECK TRAUMA
AIRWAY
ASSESSMENT WITH C-SPINE IMMOBILIZATION
NECK CT ANGIOGRAPHY
LARYNGEAL OR
TRACHEAL INJURY SUSPECTED
ESOPHAGEAL INJURY SUSPECTED
SEE SPECIFIC ALGORITHM
CAROTID VASCULAR INJURY SUSPECTED OR DIAGNOSED
C-SPINE
INJURY
CONSIDER
LARYNGOSCOPY /
TRACHEOBRONCHOSCOPY / NECK
CT SCAN
CONSIDER
ESOPHAGOSCOPY / ESOPHAGOGRAM
(+) (+)
![]()
![]()
![]()
PENETRATING NECK WOUNDS
AIRWAY ASSESSMENT AND MANAGEMENT
LIMITED FLUID RESUSCITATION
CLEAR
INDICATIONS FOR NECK EXPLORATIONS *
ZONE 1 ZONE II
ZONE III
OPERATING
ROOM
CT
Angiography screening
SYMPTOMS
PRESENT
(+) VIOLATION OF
PLATISMA
ASYMPTOMATIC
CT
Angiography screening
ANY (+)
OPERATING ROOM
FOR
NECK EXPLORATION
CT Angiography screening
ANY (+)
![]()
OPERATING ROOM FOR COMBINED CHEST/NECK APPROACH OPERATING ROOM FOR NECK EXPLORATION CONSIDER BALOON OCCLUSION OR EMBOLIZATION BY I.R.
ANY (+)
OPERATING ROOM FOR NECK EXPLORATION
* INDICATIONS FOR IMMEDIATE NECK
EXPLORATION: SHOCK, ENLARGING
HEMATOMA, ACTIVE BLEEDING,
SUBCUTANEOUS EMPHYSEMA, DYSPHAGIA, HOARSENESS,
STRIDOR, OBVIOUS TRACHEAL OR ESOPHAGEAL INJURIES.
105
BLUNT CHEST TRAUMA
PHYSICAL EXAM
POSITIVE FINDINGS CHEST X-RAY
F/U AIRLEAK
PNEUMOTHORAX RESPIRATORY DISTRESS PNEUMOTHORAX CHEST TUBE
TENSION PNEUMOTHORAX
NEEDLE DECOMPRESSION
HEMOTHORAX CHEST TUBE F/U OUTPUT
HEMOTHORAX
Ø Ø Ø Ø NGT REPEAT X-RAY UPPER GI SERIES ULTRASOUND CT SCAN CONSIDER
THORACOTOMY IF >1200CC OR >200CC/HR
POOR
DEFINITION OF DIAPHRAGM
PERICARDIAL TAMPONADE
SUBXYPHOID WINDOW / THORACOTOMY
Ø Ø Ø Ø PAIN CONTROL 02 MECH VENT IF (+) RESPIRATORY
DISTRESS AVOID FLUID OVERLOAD
FLAIL CHEST
/ PULMONARY CONTUSION
![]()
CHEST CT
PNEUMOMEDIASTINUM PNEUMOTHORAX
(+)
WIDENED
MEDIASTINUM
CHEST TUBE
(-)
![]()
106
|
ECHO /
PERICADIAL WINDOW |
|
|
|
Positive |
![]()
SEE
PENETRATING CHEST INJURY UNSTABLE FLOWCHART
107
UNSTABLE
ENDOTRACHEAL INTUBATION
CHEST TUBE PLACEMENT (UNI or BILATERAL)
LIMITED I.V. FLUIDS
1:1 TRANSFUSION
REASSESSMENT
WOUND IN THE BOX
STABLE
CHEST TUBE OUTPUT
SIGNS OF
PERICARDIAL TAMPONADE
FAST/ECHO
AND/OR PERICARDIAL WINDOW
Yes
STABLE?
CHEST X-RAY
> 1200cc
TO
OPERATING ROOM FOR PERICARDIAL
WINDOW / (L)
THORACOTOMY
or
> 200cc/hr
THORACOTOMY (open
the side of the hemothorax first)
TRANSMEDIASTINAL
TRAJECTORY
EMERGENCY
THORACOTOMY (Start on the (L) side)
No
R/O CARDIAC INJURY
Inferior
MEDIASTINUM
Superior
CONSIDER SCREENING CHEST CT ANGIOGRAPHY ECHO / PERICARDIAL WINDOW ESOPHAGOSCOPY/
ESOPHAGOGRAM/ CT ESOPHAGRAM
Inferior
R/O
ESOPHAGEAL INJURY
108
![]()
109
BLUNT ABDOMINAL TRAUMA
For evidence
based medicine literature reference list: Hoff, WS, Holevar M, Nagy KK, et. al.
Practice Management Guidelines for the Evaluation of Blunt Abdominal Trauma:
The EAST Practice Management Guidelines Work Group. J Trauma. 2002;53, 602-614
SURGICAL ABDOMEN*
TO O.R. FOR
EX-LAP
YES
NO
HEMODYNAMIC
ASSESSMENT
STABLE
ULTRASOUND
(+)
CT SCAN
SOLID ORGAN INJURY ( LIVER, SPLEEN, KIDNEY )
UNSTABLE
(-)
SERIAL
EXAMS D/C AFTER 12-24 HR
FREE FLUID ONLY
CONTRAST
EXTRAVASATION
YES
DPL** or
ULTRASOUND
(+)
NO
NON-OP MANAGEMENT PROTOCOL
PANCREATIC
INJURY
or
INTRAPERITONEAL FREE AIR
SPLEEN
REPAIR
LIVER
KIDNEY
(-)
REMOVE
ANY GRADE
TO O.R. FOR EX-LAP
SEARCH FOR OTHER SOURCES OF BLEEDING*
![]()
INTERVENTIONAL
ANGIOGRAPHY
FAILURE
O.R. FOR EX-LAP
*Hemodynamic
instability, peritonitis
**Positive
criteria for DPL in blunt trauma: >100,000 RBC/mm3 , >500 WBC mm3 or bowel content
110
STAB WOUND TO ABDOMEN
ABSENCE OF
CLEAR INDICATION
FOR EXPLORATION *
LOCATION
ANTERIOR / FLANK FLANK / POSTERIOR THORACOABDOMINAL
LOCAL WOUND EXPLORATION
(-)
(-)
TRIPLE CONTRAST CT (IV,PO,WOUND PACKING)
(+)
DPL/ LAPAROSCOPY
? OR POSITIVE
(-)
(+)
DPL ** or
LAPAROSCOPY
(-)
SERIAL EXAMS
/ CLINICAL OBSERVATION
SERIAL EXAMS
/ CLINICAL OBSERVATION
DISCHARGE
12-24 HR
(+)
REPEAT CHEST X-RAY 6 HR
![]()
![]()
*
HEMODYNAMIC INSTABILITY, EVISCERATION, PERITONEAL SIGNS, MULTIPLE WOUNDS
**
POSITIVITY CRITERIA FOR DPL: >1,000 RBC / MM3, > 500 WBC / MM3
111
![]()
![]()
|
|
|
||
|
|
NGT (+)
FOR BLOOD |
||
|
|
|||
|
|
|||
|
|
|
||
|
|
ABDOMINAL
/ PELVIC X-RAY INTRAPERITONEAL PROJECTILE |
||
|
|
|||
|
|
|||
|
|
DPL /
LAPAROSCOPY FOR TANGENTIAL WOUNDS POSITIVE |
||
|
|
|||
|
|
|||
|
|
FLANK / BACK CT WITH IV CONTRAST + CONTRAST EXTRAVASATION |
||
|
|
|||
|
|
|||
|
|
BUTTOCKS CT
WITH IV CONTRAST +/- RECTOSIGMOIDOSCOPY + |
||
|
|
|||
* ![]()
![]()
![]()
POSITIVITY CRITERIA FOR DPL: > 1,000 RBC / MM3, >500 WBC / MM3
* POSITIVITY CRITERIA FOR LAPAROSCOPY: PERITONEAL VIOLATION, INTRAABDOMINAL
BLOOD, BILE STAINING, ETC.
112
![]()
|
Head CT(-) with +LOC Or
significant facial/head/scalp trauma |
|
-LOC with significant body/tissue trauma |
|||
|
|
|
||||
|
|
|
|
|
||
![]()
![]()
113
![]()
114
Trauma
Evaluation CXR
AP pelvis
Yes
Hemodynamically
Stability No
Positive
CT
scan abdomen/ pelvis
ICU
Negative
Initiate
Massive Transfusion Protocol
No Evidence of contrast blush/extravasation
Yes
Pelvic binding
OR Angio/ embolization
Negative
Preperitoneal packing
Pelvic stabilization
115
FAST or DPL
Positive
OR
for exploratory laparotomy
ICP ≥ 20mmHg
Yes No
Yes
Head of bed ≥
30° Sedation and analgesia
Yes
ICP ≥
20mmHg
No
Yes
|
Drain CSF
if EVD present |
|
|
|
|
Consider
repeating CT scan
Yes
ICP ≥
20mmHg
No
Carefully
withdraw ICP treatment
Yes Yes
Mannitol
0.25-1.0g/kg; IV bolus PRN
3% Hypertonic
Saline
Maintain a
serum osm <320 mOsm with targeted serum Na+ of <160 mEq/L
Ensure euvolemia
Yes
ICP ≥
20mmHg
Hold if serum
Na+ >160
No
Yes
Yes
Yes
ICP ≥
20mmHg
No
No
Yes
Neuromuscular blockade
Yes
ICP ≥ No
20mmHg
Yes Yes
Decompressive
hemicraniectomy or
Bilateral
craniectomy
Barbiturate coma
116
![]()
![]()
117
![]()